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 Growth factor signaling promotes anabolic processes via activation of the 
PI3K-Akt kinase cascade. Deregulation of the growth factor-dependent PI3K-Akt 
pathway was implicated in tumorigenesis. Akt is an essential serine/threonine 
protein kinase that controls multiple physiological functions such as cell growth, 
proliferation, and survival to maintain cellular homeostasis. Recently, the 
mammalian Target of Rapamycin Complex 2 (mTORC2) was identified as the 
main Akt Ser-473 kinase, and Ser-473 phosphorylation is required for Akt 
hyperactivation. However, the detailed mechanism of mTORC2 regulation in 
response to growth factor stimulation or cellular stresses is not well understood.  
In the first project, we studied the regulation of the mTORC2-Akt signaling 
under ER stress. We identified the inactivation of mTORC2 by glycogen synthase 
kinase-3β (GSK-3β). Under ER stress, the essential mTORC2 component, rictor, 
is phosphorylated by GSK-3β at Ser-1235. This phosphorylation event results in 
the inhibition of mTORC2 kinase activity by interrupting Akt binding to mTORC2. 
Blocking rictor Ser-1235 phosphorylation can attenuate the negative impacts of 
GSK-3β on mTORC2/Akt signaling and tumor growth. Thus, our work 
demonstrated that GSK-3β-mediated rictor Ser-1235 phosphorylation in response 
to ER stress interferes with Akt signaling by inhibiting mTORC2 kinase activity. 
   vi 
In the second project, I investigated the regulation of the mTORC2 integrity. 
We found that basal mTOR kinase activity depends on ATP level, which is tightly 
regulated by cell metabolism. The ATP-sensitive mTOR kinase is required for 
SIN1 protein phosphorylation and stabilization. SIN1 is an indispensable subunit of 
mTORC2 and is required for the complex assembly and mTORC2 kinase activity. 
Our findings reveal that mTOR-mediated phosphorylation of SIN1 is critical for 
maintaining complex integrity by preventing SIN1 from lysosomal degradation. 
 In sum, our findings verify two distinct mTORC2 regulatory mechanisms via 
its components rictor and SIN1. First, GSK-3β-mediated rictor Ser-1235 
phosphorylation results in mTORC2 inactivation by interfering its substrate binding 
ability. Second, mTOR-mediated Ser-260 phosphorylation of SIN1 preserves its 
complex integrity. Thus, these two projects provide novel insights into the 
regulation of mTORC2. 
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Chapter 1 
 
Introduction 
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1.1 Growth factor-dependent PI3K-Akt signaling pathway 
Growth factors have been identified as the autocrine peptide ligands 
secreted by cells to regulate cell survival, proliferation, and differentiation 
(Cantley, 2002; Engelman et al., 2006; Fruman et al., 1998).  When growth 
factors bind to their specific receptors, it results in activation of the receptor 
tyrosine kinase that further initiates phosphorylation of the regulatory docking 
proteins on tyrosine residues. These tyrosine-phosphorylated sites play an 
important role to recruit regulatory proteins through Src Homology 2 (SH2) 
domains and proline-rich binding SH3 domains (Schlessinger and Lemmon, 
2003). These growth factor signaling-mediated protein-protein interactions 
promote phosphatidylinositol-3 kinase (PI3K) activity (Cantley, 2002; Shaw and 
Cantley, 2006). The well-defined downstream effector of the PI3K pathway is the 
Akt, also known as protein kinase B (PKB) (Cantley, 2002; Testa and Bellacosa, 
2001). Akt is a highly conserved serine/threonine protein kinase, and controls 
various biological functions such as cell proliferation, growth, survival, and 
metabolism. Perturbations of the PI3K-Akt signaling are associated with human 
diseases, such as cancers and metabolic syndromes.  
 
1.2 Downstream effectors and cellular functions of Akt 
Akt kinase is a member of the AGC (protein kinase A, G, and C) kinase 
family that act on a wide spectrum of substrates (Bellacosa et al., 2005). For 
example, Akt regulates cell cycle through phosphorylation of the cell cycle 
inhibitors p27 and p21 by causing their cytoplasmic retention (Viglietto et al., 
? ??
2002; Zhou et al., 2001a), and also through phosphorylation of the human 
oncogene product MDM2, which degrades p53 tumor suppressor gene (Zhou et 
al., 2001b). Akt regulates cell survival through inactivation of the pro-apoptotic 
protein BAD (Datta et al., 1997; del Peso et al., 1997) and inhibition of the highly 
conserved substrates identified as the FOXO transcription factors that drive the 
expression of pro-apoptotic genes (Brunet et al., 1999). Akt controls metabolism 
by suppressing glycogen synthase kinase-3 (GSK-3) and by stimulating glucose 
transport and glycolysis (Cross et al., 1995; Kohn et al., 1996). The role of Akt 
signaling in regulation of cell growth and cell size is linked to its up-regulation of 
the mTOR pathway by the phosphorylation of tuberous sclerosis complex 2 
(TSC2) (Inoki et al., 2002; Manning et al., 2002) and the proline-rich Akt 
substrate of 40 kDa (PRAS40) (Sancak et al., 2007; Vander Haar et al., 2007).  
 
1.3 Activation of Akt 
In the process of the growth factor signaling, binding of the growth factors 
to the receptors leads to activation and translocation of PI3K to the plasma 
membrane. Following activation of PI3K and accumulation of 
phosphatidylinositols-3,4,5-triphosphates (PIP3), Akt switches its cellular 
localization to the plasma membrane by binding to PIP3 via its pleckstrin 
homology (PH) domain at the N-terminal region (Figure 1-1). In addition to PH 
domain, it has been recently reported that  
? ??
 
 
 
Figure 1-1.  Growth factor signaling pathway 
Receptors regulated by growth factors activate PI3 Kinase, which recruits 
inactive Akt to the plasma membrane. Recent report demonstrates that 
ubiquitination of Akt by TRAF6 is required for its membrane translocation. 
Moreover, both phosphorylation events by PDK1 and mTORC2 are required for 
full activation of Akt. 
? ??
TRAF6 ubiquitinates Akt and assists its membrane translocation (Yang et al., 
2009). In the meantime, two residues of Akt are phosphorylated for its full 
activation. The Thr-308 residue of Akt that locates on its activation loop is 
phosphorylated by the phosphoinositide-dependent kinase (PDK1), and this 
phosphorylation is required for kinase activity of Akt (Alessi et al., 1997; 
Stephens et al., 1998). The second Ser-473 residue resides at the C-terminal 
region of Akt, and has been defined as the hydrophobic regulatory site. Lately, 
mTORC2 has been identified as the major Akt Ser-473 kinase (Sarbassov et al., 
2005).  
Whether Thr-308 phosphorylation of Akt is dependent on Ser-473 
phosphorylation is still controversial. In human cancer cells (HT-29 colon, A549 
lung, HEK-293T kidney, HeLa cervical, and PC3 prostate), knockdown of mTOR 
or rictor expression decreases Akt phosphorylation on both Ser-473 and Thr-308 
sites (Sarbassov et al., 2005). In this setting, inhibition of mTORC2-mediated 
Ser-473 phosphorylation results in the decreased Thr-308 phosphorylation of Akt, 
indicating the importance of Ser-473 phosphorylation for Thr-308 phosphorylation. 
Moreover, prior Ser-473 phosphorylation is required for PDK1 to phosphorylate 
Thr-308 in the immortalized cells (Scheid et al., 2002). However, phosphorylation 
of Akt Thr-308 is not affected by loss of Ser-473 phosphorylation in mTORC2-
deficient embryos and MEFs (Guertin et al., 2006). This difference reflects the 
highly active state of the Akt signaling in cancer cells because Thr-308 
phosphorylation of Akt can be boosted by its Ser-473 phosphorylation. In this 
regard, mTORC2 signaling might be amplified to hyper-activate Akt signaling that 
? ??
is engaged in tumor growth and progression. Thus, inhibition of mTORC2 in 
cancer cells should give stronger effects on Akt signaling pathway than in normal 
tissues.   
 
1.4 Mammalian target of rapamycin (mTOR) 
mTOR was initially identified as the target of rapamycin, which is applied 
as a potential anti-cancer drug and a potent immunosuppressant. The effects of 
rapamycin on inhibiting proliferation stem from the inactivation of mTOR, an 
essential regulator of the highly-conserved growth pathway (Harris and Lawrence, 
2003). mTOR contains 2,549 amino acids with the predicted molecular weight of 
290 kDa. Structurally, mTOR possesses N-terminal tandem HEAT repeats, 
followed by a FRB domain and a C-terminal kinase domain (Figure 1-2). HEAT 
repeat is derived from four proteins Huntington, Elongation factor 3, PR65/A, 
TOR, and is composed of repeated protein motifs (about 47 amino acid residues 
that form two anti-parallel ?-helices and two turns). HEAT repeats compose a 
rod-like helical structure for regulation of the protein-protein interaction. The FRB 
domain is the C-terminal stretch of 100 amino acids, and is the docking site for 
FKBP12/rapamycin complex. Recent reports indicated that the lipid second 
messenger phosphatidic acid (PA) binds FRB domain and enhances mTOR 
activity. However, the molecular mechanism of mTOR activation by PA remains 
unclear. The mTOR kinase domain structurally resembles the kinase domain of 
PI3K (a lipid kinase), but functions as a serine/threonine protein kinase.  
 
? ??
 
 
 
 
Figure 1-2.  The domain structures of the TOR protein 
In 1990s, yeast genetic screens first identified two rapamycin target genes, called 
TOR 1 and 2. The high degree of conservation among species, from mammals to 
yeast, strongly suggests that TOR is an essential cell growth regulator. mTOR is 
a Serine/Threonine protein kinase with a predicted molecular weight of 290 kDa. 
Structurally, mTOR contains multiple tandem HEAT repeats in the N-terminal 
region followed by a FRB domain and a C-terminal kinase domain. 
? ??
1.5 mTOR complexes 
mTOR and its binding partner, mammalian lethal with SEC13 protein 8 
(mLST8), exist at least in two distinct complexes (Figure 1-3). mLST8 is a small 
subunit that contains seven WD40 repeats and physically associates with the 
mTOR kinase domain (Jacinto et al., 2004; Sarbassov et al., 2004). Interaction 
between mTOR and mLST8 is required for the kinase activity of mTOR (Kim et 
al., 2003). The interaction between raptor and mTOR/mLST8 defines the mTOR 
Complex 1 that regulates protein translation by phosphorylation of its substrates 
4EBP1 (eIF4E binding protein 1) and S6K1 (p70 ribosomal protein S6 kinase 1) 
(Fingar and Blenis, 2004). 4EBP1 binds translational initiator eIF4E and inhibits 
cap-dependent mRNA translation under basal condition (Gingras et al., 2001). 
Upon growth factor stimulation, mTORC1 phosphorylates 4EBP1 and relieves its 
suppressive impact on eIF4E to initiate protein translation. S6K1 binds to eIF3 
(eukaryotic initiation factor 3) and remains inactive (Holz et al., 2005). The 
activated mTORC1 upon growth factor induction results in S6K1 phosphorylation 
and activation. The active S6K1 phosphorylates ribosomal protein S6 to stimulate 
protein translation and cell growth (Jeno et al., 1988; Thomas, 2002).   
The second mTOR complex (mTORC2) is assembled by binding of 
mTOR/mLST8 to rapamycin-insensitive companion of mTOR (rictor) and 
mammalian SAPK interacting protein 1 (SIN1) (Jacinto et al., 2006; Jacinto et al., 
2004; Sarbassov et al., 2004). These two unique components SIN1 and rictor 
most likely carry the regulatory functions of this kinase complex. Sin1 contains a  
? ??
  
 
 
Figure 1-3.  Current models of the mTOR complexes 
mTOR forms two structurally and functionally distinct molecular complexes: 
mTORC1 and mTORC2. mTORC1 is composed of mTOR, raptor and mLST8 
(also called G?L), which is highly sensitive to rapamycin inhibition. The 
rapamycin insensitive complex mTORC2 is composed of mTOR, mLST8, rictor 
and SIN1. Both complexes were shown to regulate downstream targets through 
phosphorylation on the hydrophobic motif.  
? ???
N-terminal Conserved Region In the Middle (CRIM) domain, the Raf-like Ras 
binding domain (RBD)  and a C-terminal PH domain (Schroder et al., 2007). 
CRIM domain is a highly conserved region in the SIN1 family. SIN1 RBD domain 
suggests that Ras is a potential regulator of mTORC2. SIN1 PH domain implies 
the mTORC2 localization at the plasma membrane. However, the functional roles 
of these domains are yet to be characterized.  
Rictor is a more conserved and larger protein than SIN1. The human rictor 
protein contains 1,708 amino acids and its sequence analysis did not reveal any 
homology to known functional domains or proteins (Sarbassov et al., 2004). In 
spite of this, rictor is a phospho-protein and the functional characterization of this 
post-translational modification might provide insights in regulation of mTORC2. In 
recent reports, some phosphorylation sites of rictor were identified, and the Thr-
1135 phosphorylation is the growth factor dependent. The functional 
characterization determined that S6K1 is the kinase of rictor Thr-1135, and this 
site has been shown to carry the negative impact on mTORC2 by providing the 
binding site for the 14-3-3 adaptor proteins (Dibble et al., 2009; Julien et al., 2010; 
Treins et al., 2010). However, our functional studies indicated that this 
phosphorylation occur independent of mTORC2. Importantly, rictor Thr-1135 site 
was not essential for regulating mTORC2 kinase activity (Boulbes et al., 2010).  
 
1.6 The mechanism of mTOR inhibition by rapamycin 
Rapamycin binds proline isomerase FKBP12 to form a complex, which 
specifically interacts with the FRB domain of mTOR and inhibits its function 
? ???
(Figure 1-4) (Kim et al., 2002). In contrast, the FRB domain of mTOR within 
mTORC2 is not accessible so that mTORC2 cannot be inhibited by rapamycin 
binding. However, prolonged rapamycin treatment interferes with the assembly of 
mTORC2. For examples, the prolonged rapamycin treatment results in less 
abundance of mTORC2 and inhibition of Akt in several cell types, mostly 
lymphoma cells (Sarbassov et al., 2006). 
 
1.7 Downstream effectors of mTORC2 
mTORC2 has been proposed to control phosphorylation of the AGC 
kinases members including SGK1 (serum and glucocorticoid induced protein 
kinase 1) (Garcia-Martinez and Alessi, 2008) and PKC? (protein kinase C?) 
(Facchinetti et al., 2008; Ikenoue et al., 2008). mTORC2 has been identified as 
the Ser-422 kinase of SGK1, which functions to stabilize the expression of the 
ENaC (epithelial sodium channel) to induce sodium transport into epithelial cells 
and maintain the sodium homeostasis (Loffing et al., 2006). Besides, mTORC2 
controls the actin-cytoskeleton probably through phosphorylation of PKC? on 
Ser-657, but the detailed mechanism remains to be addressed.  
The most critical finding about mTORC2 function is the confirmation of this 
kinase complex as the major Akt kinase at the hydrophobic motif (HM) site Ser-
473 (Sarbassov et al., 2005). The functional role of mTORC2  
? ???
 
  
 
 
 
Figure 1-4.  Rapamycin/FKBP12 binds and inhibits mTOR 
Upon entering the cells, rapamycin binds a small protein receptor called FKBP12 
(FK506-binding protein 12 kDa) to form a complex. This complex specifically 
binds mTOR and inhibits its function. 
? ???
as the regulatory kinase of Akt has been supported by the mouse genetic studies 
(Guertin et al., 2006; Jacinto et al., 2006; Shiota et al., 2006; Yang et al., 2006). 
In addition to Ser-473, mTORC2 has been shown to phosphorylate Akt on Thr-
450 turn motif (TM) site (Facchinetti et al., 2008; Ikenoue et al., 2008). Although 
both sites are regulated by mTORC2, but their roles are different. Regulation of 
the Akt HM site Ser-473 site is linked to the growth factor-mediated mTORC2 
activation. The neighboring TM site Thr-450 of Akt is constitutively 
phosphorylated by mTORC2 and is required to control Akt protein stability (Oh et 
al., 2010). During Akt protein translation, mTORC2 can associate with the 
actively translating ribosome and mediate the Thr-450 phosphorylation. This 
phosphorylation event facilitates the proper folding of the Akt nascent polypeptide, 
which prevents misfolded Akt from targeting for K48-linked ubiquitination and 
proteasomal degradation.      
 
1.8 Glycogen synthase kinase-3? (GSK-3?) 
Glycogen Synthase Kinase-3 (GSK-3) is a multifunctional and 
evolutionally conserved serine/threonine protein kinase (Cohen and Frame, 
2001). GSK-3 was discovered as the kinase of glycogen synthase that controls 
glycogen metabolism (Cross et al., 1995). Two human genes encode GSK-3 
isoforms, GSK-3? (51 kDa) and GSK-3? (46 kDa), which exhibit 84 % overall 
identity and 98 % identity of their kinase domains. The major dissimilarity 
between two isoforms is that GSK-3? contains an extra N terminal glycine-rich 
stretch. Besides, these GSK-3 isoforms are functionally distinct because GSK-3? 
? ???
cannot rescue the embryonically lethal phenotype of GSK-3? deficient mice 
(Hoeflich et al., 2000). Several recent reports suggest the potential differences 
between these two isoforms (Kerkela et al., 2008; MacAulay et al., 2007). For 
examples, GSK-3? inhibition is more effective in causing NF-?B- and cAMP-
responsive element-dependent transactivation (Liang and Chuang, 2006). By 
contrast, GSK-3? depletion has more robust effects in suppressing neuronal 
death and improving glucose tolerance in skeletal muscle (Liang and Chuang, 
2007; Patel et al., 2008).    
GSK-3 function is regulated by its phosphorylation. The phosphorylation of 
the N-terminal serine residue (GSK-3? on Ser-9; GSK-3? on Ser-21) decreased 
their kinase activity. Certain kinases such as Akt, p90RSK, protein kinase A, and 
protein kinase C could phosphorylate these serine residues. The phosphorylated 
serine residue serves as a pseudo substrate that hinders the access of 
substrates to the active site of GSK-3. By contrast, GSK-3 activity is enhanced by 
phosphorylation of the tyrosine residue (GSK-3? on Tyr-216 and GSK-3? on Tyr-
279), which might take place by autophosphorylation or by additional tyrosine 
kinases. The regulatory mechanism of the GSK-3 tyrosine phosphorylation 
remains ill-defined (Frame and Cohen, 2001; Grimes and Jope, 2001).  
Moreover, the priming phosphorylation of the substrate by another kinase 
is required for GSK-3 function. The priming phosphorylation takes place on a 
serine residue resided four amino acids C-terminal to the GSK-3 phosphorylation 
site. For instance, casein kinase II performs the priming phosphorylation of 
? ???
glycogen synthase, and the priming phosphorylation of ?-catenin by casein 
kinase I? are required for GSK-3 action (Fiol et al., 1987; Liu et al., 2002).     
 
1.9 Biological functions of GSK-3?  
GSK-3? regulates various biological pathways such as Wnt/?-catenin 
(Seidensticker and Behrens, 2000) and Hedgehog pathways, apoptotic process, 
and cell cycle. GSK-3? dysfunction results in multiple human diseases including 
bipolar disorder, Alzheimer’s disease, cancer and diabetes. In the development 
of type II diabetes, GSK-3? activation associates with insulin resistance. The 
impaired response of peripheral tissues (muscle, fat and liver) to insulin signals 
causes deficient glucose uptake (Tanabe et al., 2008). GSK-3? has been 
reported to be activated under ER stress (Huang et al., 2009), and ER stress is 
the potential cause of insulin resistance and type II diabetes (Ozcan et al., 2004). 
Specific GSK-3? inhibitors stimulate insulin-dependent glucose uptake (Ring et 
al., 2003). However, the mechanisms of the GSK-3?-dependent insulin 
resistance remain to be determined.  
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Chapter 2 
 
Materials and Methods 
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2.1 Cell lines and culture  
MEFs, HeLa, MDA-MB-435, HEK-293T and COS-7 cells were obtained 
from the American Type Culture Collection and cultured in DMEM/F12 with 10% 
FBS and penicillin/streptomycin in 5% CO2 at 37°C. Cell lines were cultured at a 
density that allows cell division throughout the course of the experiment. MEFs 
were transfected by Dreamfect reagent following the manufacturer's protocol.  
 
2.2 Antibodies and reagents 
Antibodies to Xpress, myc and V5 tag from Invitrogen; antibodies to 
phospho-Ser2481 mTOR, phospho-Thr1135 and phospho-Ser1235 rictor, mTOR, 
rictor, raptor, phospho-Ser260 SIN1, phospho-Ser473, phospho-Thr450 and 
phospho-Thr308 Akt, Akt, phospho-Ser641 GS, GS, phospho-Ser9 and phospho-
Tyr216 GSK-3?, GSK-3?, GSK-3?, phospho-Thr980 PERK, PERK, p27, S6K1, 
phospho-Thr389 S6K1 from Cell Signaling Technologies; antibodies to rictor and 
tubulin and horseradish peroxidase (HRP)-labeled anti-rabbit, anti-mouse, and 
anti-goat secondary antibodies from Santa Cruz Biotechnology.  
Reagents were obtained from the following sources: Dulbecco's modified 
Eagle's medium (DMEM)/F12 from Life Technologies; fetal bovine serum (FBS) 
from HyClone. FuGENE 6 transfection reagent and Complete protease inhibitor 
cocktail from Roche Applied Science; protein G-Sepharose from Pierce; insulin-
like growth factor I (IGF-1) from Peprotech; thapsigargin, tunicamycin, BIO and 
SB-216763 from Sigma; Dreamfect transfection reagent from OZ Biosciences.  
 
? ???
2.3 Letiviral shRNAs and plasmid DNAs 
Lentiviral shRNAs targeting humanGSK-3? and GSK-3? were obtained 
from Sigma (MISSION shRNA). The targeting sequences of the oligo-nucleotides 
are as follows:  
GSK-3? sense strand, GCTGAGCTGTTACTAGGACAA (NM_002093.2-974s1c1);  
GSK-3? sense strand, CCCAAACTACACAGAATTTAA (NM_002093.2-1087s1c1);  
GSK-3? sense strand, CGGACATCAAAGTGATTGGCA (NM_019884.1-473s1c1);  
GSK-3? sense strand, CCTCTCTTCAACTTCAGTGCT (NM_019884.1-1375s1c1). 
Lentiviral shRNAs targeting human mTOR were generated and applied as 
described previously (Sarbassov et al., 2005). 
The pcDNA3-hemagglutinin (HA)-GSK-3?-wild type and pBabe-puro-GSK-
3? (S9A) were obtained from Addgene. Plasmids pRK5-myc-GCP2, -myc-rictor, 
myc-raptor, myc-mTOR-WT, myc-mTOR-KD, HA-mLST8, and HA-tubulin were 
kindly provided by David M. Sabatini (Whitehead Institute for Biomedical 
Research, Cambridge, MA). The pcDNA3.1-Sin1.1-V5 and pcDNA4-Xp-rictor 
were generated by the TOPO cloning system (Invitrogen). 
 
2.4 Mutagenesis of rictor 
The rictor complementary DNA (cDNA) from the pRK5 plasmid was re-
sub-cloned to pcDNA4 by means of the Xpress tag with the pcDNA4/HisMax 
TOPO TA Expression Kit from Invitrogen. The large size of the plasmid (11 kb) is 
incompatible with the polymerase chain reaction (PCR)-based mutagenesis. To 
decrease the size of the plasmid to 6 kb, we sub-cloned the fragment of rictor 
containing the sequences of the phospho-mutants into pBluescript by Bgl II and 
? ???
Not I digestion. The primers for mutagenesis were designed based on the 
QuikChange Primer Design Program (http://www.stratagene.com). The 
pBluescript plasmid containing the rictor fragment was mutagenized with the 
QuikChange II XL Mutagenesis Kit (Stratagene). After validation of mutations by 
sequencing, the mutated rictor fragments were reinserted into the Xp-rictor 
pcDNA4 plasmid by Bgl II and Not I digestion. 
 
2.5 Retroviral production and infection 
Retroviral vectors were propagated in and purified from XL-10 Gold 
bacterial cells and co-transfected together with the ?VPR and VSVG plasmids 
into actively growing cells. One day before transfection, HEK 293T cells (1.2 ? 
106) were placed on 6-cm dishes in 3 ml of DMEM supplemented with 10% FBS. 
For production of retroviruses, HEK 293T cells were transfected by the calcium 
phosphate method with 3 mg of transfer vector pMSCV, 0.6 mg of envelope 
coding plasmid VSVG, and 2.4 mg of Gag-pol-expressing plasmid. 
Retroviruses were harvested 48 hours after transfection and centrifuged at 
3,000g at 4°C for 15 min to eliminate any remaining HEK 293T cells. One day 
before infection, cells to be infected were seeded in six-well plates. Viral 
supernatant was added at a ratio of 1:1 to the culture medium in the presence of 
polybrene (8 mg/ml), and the cells were centrifuged at 1,800 rpm for 45 min to 
increase the infection rate. Cells were incubated with retroviruses for 24 hours. A 
second infection was performed the next day following the same protocol. After 
? ???
an additional 24 hours of recovery in regular medium, infected cells were 
passaged and selected with puromycin (2 mg/ml for 2 days). 
 
2.6 Immunoprecipitations and kinase assays 
For immunoprecipitation experiments, the lysis buffer contained 0.3% 
CHAPS instead of 1% Triton to preserve the integrity of the mTOR complexes. 
Two micrograms of rictor antibody was added to the cleared cellular lysates (1 
mg of protein content in 700 ml) and incubated with rotation at 4°C for 90 min. 
After 1 hour of incubation with 40 ml of 50% slurry of protein G-agarose, 
immunoprecipitates captured by protein G-agarose were washed four times with 
CHAPS-containing lysis buffer and once with rictor-mTOR kinase buffer [25 mM 
Hepes (pH 7.5), 100 mM potassium acetate, and 2 mM MgCl2].  
For in vitro mTORC2 kinase reactions, immunoprecipitates were 
incubated in a final volume of 15 ml at 37°C for 20 min in rictor-mTOR kinase 
buffer containing 500 ng of inactive Akt1-GST and 1 mM ATP. The reaction was 
stopped by the addition of 235 μl of ice-cold enzyme dilution buffer [20 mM Mops 
(pH 7.0), 1 mM EDTA, 0.3% CHAPS, 5% glycerol, 0.1% 2-mercaptoethanol, and 
bovine serum albumin (BSA; 1 mg/ml)]. After a quick spin, the supernatant was 
removed from the protein G-agarose, and the 15-μl portion was analyzed by 
immunoblotting for phospho-Ser473 Akt and total Akt. The pelleted protein G-
agarose beads were also analyzed by immunoblotting to determine the 
abundance of rictor, Sin1, and mTOR in the immunoprecipitates.  
? ???
For in vitro GSK-3? kinase reaction, immunoprecipitates were prepared 
from MDA-MB-435 cell lysates with rictor antibody. GSK-3? was 
immunoprecipitated from lysates of human embryonic kidney (HEK) 293T cells 
expressing GSK-3? that were treated with tunicamycin (2 μg/ml) for 3 hours 
before cell harvest. In vitro GSK-3? kinase assays were performed at 37°C for 30 
min in the final volume of 25 ml of GSK-3? kinase buffer containing 4 mM Mops 
(pH 7.2), 2.5 mM ?-glycerophosphate, 1 mM EGTA, 0.4 mM EDTA, 4 mM MgCl2, 
0.05 mM dithiothreitol (DTT), 40 μM BSA, and 1 mM ATP. Immunoprecipitates 
captured by protein G-agarose were washed with rictor-mTOR kinase buffer for 
subsequent in vitro mTORC2 kinase reactions as indicated above. 
 
2.7 Cell lysis and immunoblotting 
Cells were rinsed with ice-cold phosphate-buffered saline (PBS) before 
lysis in buffer containing 40 mM Hepes (pH 7.5), 120 mM NaCl, 1 mM EDTA, 10 
mM sodium pyrophosphate, 10 mM sodium glycerophosphate, 50 mM NaF, 1% 
Triton X-100, and protease inhibitor cocktail (Roche Applied Science). The 
scraped lysates were incubated for 20 min at 4°C to complete lysis. The soluble 
fractions of cell lysates were isolated by centrifugation at 13,000 rpm at 4°C for 
12 min. Samples of the cellular lysates containing an equal amount of proteins 
were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and 
transferred to polyvinylidene difluoride (PVDF) membrane. Proteins were then 
visualized by immunoblotting and detected with enhanced chemiluminescence 
(ECL) with the Immobilon Western kit (Millipore). 
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2.8 Preparation of liver tissue extracts for immunoblotting 
Powdered livers were homogenized on ice with a Teflon glass 
homogenizer in 1 ml of ice-cold buffer [20 mM tris-HCl (pH 7.4), 20 mM NaCl, 1 
mM EDTA, 20 mM ?-glycerophosphate, 5 mM EGTA, 1 mM DTT, and 1 mM 
phenylmethylsulfonyl fluoride (PMSF)] containing 0.1% Tween 20 and were 
centrifuged at 1,000g for 20 min at 4°C to pellet insoluble material. The protein 
concentration of the supernatant was determined. Liver extract samples 
(containing 50 to 100 mg of total protein) were subjected to SDS-PAGE in 7.5% 
polyacrylamide gels followed by Western blot analysis with indicated antibodies. 
 
2.9 Tumor xenografts 
MEFs constitutively expressing wild-type, S1235A, or S1235D-rictor were 
transformed by H-Ras overexpression. Protein extracts from wild-type-, S1235A-, 
or S1235D-rictor-expressing MEFs indicated equal protein amounts of rictor and 
H-Ras by Western blotting analysis. The MEFs (5 ? 106 cells per mouse) were 
injected subcutaneously into the upper flank region of 6-week-old 
immunodeficient nude mice (n = 5 for each group). 
Tumor size was measured after 15 days and the tumor volume was 
determined with the standard formula L ? W2 ? 0.5, where L is the longest length 
and W is the shortest length in millimeters. The differences in the tumor volume 
from mice injected by wild-type-, S1235A-, or S1235Drictor-expressing MEFs 
? ???
were compared by one-way analysis of variance (ANOVA). Nude mice were 
killed and the tumors were excised. 
 
2.10 In vitro substrate binding assay 
For the in vitro substrate binding assay, rictor immunoprecipitates were 
incubated in a final volume of 15 ml at 37°C for 20 min in rictor-mTOR kinase 
buffer containing 100 ng of Akt1-GST with or without ATP. The 
immunoprecipitates were then washed four times with CHAPS-containing lysis 
buffer. The pelleted protein G-agarose beads were analyzed by immunoblotting 
to determine the protein abundance of Akt1-GST, rictor, Sin1, and mTOR in the 
immunoprecipitates. 
 
2.11 Drosophila RNAi and analysis 
RNAi against Drosophila GSK-3 was performed as previously described 
(Sarbassov et al., 2005). dsRNA targeting Drosophila GSK-3 was synthesized by 
in vitro transcription (IVT) in 20-ml reactions with a MEGAscript T7 kit (Ambion). 
DNA templates for IVT were generated by PCR from total Drosophila S2 cellular 
genomic DNA. The primers (which incorporated a 5' and 3' T7 promoter) for 
dGSK-3 dsRNA synthesis were as follows:  
The dGSK-3 forward primer:  
5'-TAATACGACTCACTATAGGCCGTTGACGAGTTTGTGTGT 
The dGSK-3 reverse primer:  
5'-TAATACGACTCACTATAGGAAACTCGGCGACTGTTTGTT 
? ???
The underlined region indicates the T7 promoter sequence. The dsRNA products 
were purified with an Invitrogen PureLink PCR Purification Kit. Final dsRNA 
concentrations were measured on a Nano-Drop spectrophotometer.  
Drosophila S2 cells were prepared for dsRNA addition by seeding 1 ? 106 
cells in 2 ml of Drosophila Schneider's medium to each well in six-well culture 
plates. dsRNAs were transfected with FuGENE 6 (Roche). Briefly, 6 μl of 
FuGENE was added to 94 μl of Drosophila SFM (Invitrogen) followed by the 
addition of 4 mg of dGSK-3 dsRNA. Four micrograms of green fluorescent 
protein (GFP) dsRNA was used as control. Tubes were gently mixed and 
incubated for 20 min at room temperature. FuGENE-dsRNA complexes were 
then administered to cells by adding the entire mixture drop-wise around wells 
and then swirling to ensure even dispersal. After 6 hours of dsRNA addition, the 
medium was changed to avoid potential negative effects of FuGENE on cell 
viability. Additional FuGENE-dsRNA complexes were added to wells on each of 
the following 3 days. After 4 days of incubation to allow turnover of the target 
mRNAs, cell lysates were subjected to immunoblotting for the amounts of 
phospho- and total dAkt, GSK-3, and tubulin. 
 
2.12 Purification of the soluble FLAG-mLST8/myc-mTOR heterodimer 
FLAG-mLST8 was co-transfected with myc-mTOR cDNA in HEK-293T 
cells. After a 48 h transfection, cells were washed with cold PBS, lysed with 0.3% 
CHAPS buffer, and incubated with mild agitation for 20 min at 4 °C. The lysate 
was transferred to the spinning columns for centrifugation for 15 min at 10,000 
? ???
rpm. After centrifugation, the supernatant was used for the FLAG affinity 
purification as described previously (Yip et al., 2010). FLAG M2 affinity resins 
were washed three times in 0.3% CHAPS lysis buffer and packed into a 10 ml 
Bio-Rad column. The cellular lysates were applied through the column seven 
times. After running the lysates, the column was washed with 20 ml of lysis buffer 
and 10 ml of elution buffer (40 mM HEPES, pH 7.4, 500 mM NaCl, 0.1% CHAPS). 
The FLAG-mLST8/myc-mTOR heterodimer was eluted by the elution buffer with 
0.5 mg/ml of the FLAG peptide. The eluted fractions from number 2 to 6 were 
combined, dialyzed with mTORC2 kinase buffer, and concentrated with Millipore 
Amicon Ultra-15 centrifugal filter units. The purified FLAG-mLST8/myc-mTOR 
heterodimer was analyzed by immunoblotting and applied for the in vitro 
mTORC2 assembly. 
 
2.13 The in vitro mTORC2 assembly and kinase reaction 
Myc-rictor and SIN1-V5 cDNAs were co-transfected in HEK-293T cells. 
After 48-h transfection, cells were washed with cold PBS, lysed with 0.3% 
CHAPS buffer, and subjected for centrifugation for 15 min at 10,000 rpm. The 
supernatant was applied for immunoprecipitation with anti-V5 antibody. The myc-
rictor/SIN1-V5 immunoprecipitates were incubated with or without the purified 
soluble FLAG-mLST/myc-mTOR heterodimer at room temperature for 2 h in 
mTORC2 kinase buffer with 1 mM ATP. After washing three times with 0.3% 
CHAPS lysis buffer, the immunoprecipitates were used for the in vitro mTORC2 
kinase reaction with wild-type Akt as the substrate.   
? ???
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Rationale 
Although the functional role of mTORC2 as the major regulatory Ser-473 
kinase of Akt is well established, the regulatory mechanisms of mTORC2 
remains poorly characterized. Within mTORC2, the essential components rictor 
and SIN1 most likely carries the regulatory functions of this kinase complex. 
Particularly, rictor is a phospho-protein and the functional characterization of this 
post-translational modification might provide insights in regulation of mTORC2. In 
this study, I aimed to identify rictor phosphorylation site(s) that is essential for 
mTORC2 regulation.  
Growth factor signaling is sensitive to certain stress conditions, such as 
endoplasmic reticulum (ER) stress. ER stress is a common pathophysiological 
state associated with metabolic and neuronal disorders as well as human 
cancers. Here, we found that inhibition of the mTORC2 and Akt signaling by ER 
stress is associated with the increased rictor phosphorylation on Ser-1235. This 
phosphorylation event occurs in mouse tissues under ER stress condition, 
suggesting that rictor Ser-1235 has a biological function and could potentially 
affect the mTORC2 kinase activity. Therefore, I initiated this research project to 
further investigate whether mTORC2 kinase activity is suppressed under ER 
stress. I also aimed to identify the kinase for rictor Ser-1235 phosphorylation, and 
to determine the biological functions of rictor Ser-1235 phosphorylation. 
 
 
Results 
? ???
3.1. ER stress-mediated inhibition of Akt signaling associates with rictor 
phosphorylation at Ser-1235  
To address if the mTORC2 activity is sensitive to stress condition, we 
analyzed its activity and rictor phosphorylation in response to osmotic stress. 
Acute osmotic stress induced by treatment of cells with 0.5 M sorbitol caused 
inhibition of the mTORC2-Akt signaling, which was shown by the substantial 
decrease of the mTORC2 kinase activity and Akt Ser-473 phosphorylation 
(Figure 3-1A). Notably, the osmotic stress induced by sorbitol led to increased 
rictor phosphorylation at Ser-1235 as shown in cell lysate and rictor 
immunoprecipitate (Figure 3-1A). Osmosis of water from cells is linked to ER 
stress induction (Lee and Linstedt, 1999). Our initial experiment in tissue culture 
of cancer cells indicates a stress-inducible phosphorylation of rictor on Ser-1235. 
We hypothesized that if this site has a biological function, this phosphorylation 
event would also occur in mouse tissues under ER stress.  
Thapsigargin and tunicamycin are two well-characterized compounds 
known to induce ER stress. Thapsigargin is an inhibitor of SERCA 
(sarco/endoplasmic reticulum calcium ATPase). Thapsigargin inhibits the cell to 
transport calcium to the endoplasmic and sarcoplasmic reticula and results in the 
elevated cytosolic calcium concentration. The disruption of homeostatic balance 
of the Ca2+ concentration in the ER leads to ER stress induction.  
? ???
                                
Figure 3-1.  Inhibition of mTORC2 signaling by ER stress is linked to rictor 
phosphorylation. 
(A) Inhibition of mTORC2 activity by osmotic stress correlates with rictor Ser-
1235 phosphorylation. HEK 293T cells were incubated with 0.5 M sorbitol for 30 
min to induce osmotic stress. Rictor immunoprecipitates (IP) were used for in 
vitro kinase assays with full-length wild-type Akt1 as the substrate. (This figure 
was adopted from our previously published work in Sci. Signal. 4, ra10, 2011; the 
permission was received from the journal.) 
? ???
Tunicamycin blocks the N-linked protein glycosylation and causes incorrect 
protein folding and membrane targeting. The accumulation of the misfolded 
proteins triggers ER stress. To extend our cellular data to the in vivo study, we 
injected mice with both compounds to induce ER stress and analyzed the mouse 
liver extracts. The induction of ER stress was indicated by phosphorylation of the 
ER stress marker PERK (protein kinase RNA-like endoplasmic reticulum kinase) 
at Thr-980 (Figure 3-1B). Similarly, ER stress resulted in decreased Akt Ser-473 
phosphorylation and augmented rictor Ser-1235 phosphorylation. The data 
implied that Ser-1235 is a novel ER-stress-inducible rictor phosphorylation site.  
 
3.2. Inhibition of GSK-3 prohibits ER stress-mediated Ser-1235 
phosphorylation of rictor and up-regulates mTORC2 kinase activity 
Based on the sequence alignment result, the surrounding sequence of 
rictor Ser-1235 (SS-S1235-PS) resembles the BCL-3 (B cell lymphoma 3-encoded 
protein) Ser-394 (SS-S394-PS) site known to be phosphorylated by GSK-3. 
Importantly, the GSK-3 kinase activity is inducible by ER stress (Song et al., 
2002). Thus, it is possible that stress-induced rictor phosphorylation at Ser-1235 
is regulated by GSK-3. Indeed, treatment of cells with tunicamycin and 
thapsigargin led to GSK-3 activation, as shown by the increased tyrosine 
phosphorylation of GSK-3 at Tyr-216 (Hughes et al., 1993; Wang et al., 1994) 
and the elevated phosphorylation of the GSK-3 substrate, glycogen synthase 
(GS) at Ser-641 (Figure 3-2A). Moreover, inhibition of GSK-3 in stressed cells by  
? ???
                              
 
Figure 3-1.  Inhibition of mTORC2 signaling by ER stress is linked to rictor 
phosphorylation. 
(B) Regulation of rictor Ser-1235 phosphorylation by ER stress in mice. 
Thapsigargin (1 μg/g in PBS) or tunicamycin (2 μg/g in 150 mM glucose) was 
injected intraperitoneally into 4-month-old mice for 24 hours to induce ER stress. 
(This figure was adopted from our previously published work in Sci. Signal. 4, ra10, 2011; 
the permission was received from the journal.)  
? ???
                
Figure 3-2.  ER stress–dependent phosphorylation of rictor at Ser-1235 
and mTORC2 signaling requires GSK-3 activity. 
(A) GSK-3 mediates ER stress-induced phosphorylation of rictor at Ser-1235. 
MDA-MB-435 cells were treated with 2 μM thapsigargin (TG) or tunicamycin (TM) 
(2 μg/ml) for 6 hours, and then with 5 mM of the GSK-3 kinase inhibitor BIO for 3 
hours before cell harvest. (This figure was adopted from our previously published work 
in Sci. Signal. 4, ra10, 2011; the permission was received from the journal.) 
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 6-bromoindirubin-3?-oxime (BIO) prevented the induction of rictor 
phosphorylation at Ser-1235, implying that GSK-3 regulates rictor 
phosphorylation. The ER stress-mediated dephosphorylation of Akt was also 
dependent on GSK-3 function, demonstrating that Akt Ser-473 phosphorylation is 
inversely correlated with rictor Ser-1235 phosphorylation.   
We further studied if GSK-3 regulates Akt signaling in cell culture 
mediums containing high (10 %) or low (1 %) serum. Inhibition of GSK-3 by two 
distinct inhibitors, BIO and SB-216763, promoted Akt Ser-473 and Thr-308 
phosphorylation in both high- and low-serum conditions (Figure 3-2B). So, 
inhibition of GSK-3 suffices to activate Akt signaling in different conditions, which 
is coherent to recent reports that GSK-3 inhibitors cause Akt-dependent 
phenotypes including glucose uptake and cell proliferation (Mussmann et al., 
2007; Ring et al., 2003). 
Because inhibition of GSK-3 also reduced rictor phosphorylation at Ser-
1235, we reasoned that GSK-3 inhibition-dependent Akt activation may associate 
with the changes of mTORC2 activity. To examine this idea, we immunopurified 
mTORC2 from cells treated with or without GSK-3 inhibitors and conducted the in 
vitro mTORC2 kinase assay using full length GST-Akt as the substrate. We 
detected a higher kinase activity of mTORC2 with GSK-3 inhibition (Figure 3-2C). 
These results indicated that inhibition of GSK-3 augments mTORC2 kinase 
activity; moreover, this impact was coherently accompanied with the declined 
rictor phosphorylation at Ser-1235.  
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Figure 3-2.  ER stress–dependent phosphorylation of rictor at Ser-1235 
and mTORC2 signaling requires GSK-3 activity. 
(B) GSK-3 inhibitors induce Akt activation. MDA-MB-435 cells were incubated 
with 5 μM BIO or 10 μM SB-216763 for 5 hours under low- or high-serum (1 or 
10% FBS, respectively) conditions. (This figure was adopted from our previously 
published work in Sci. Signal. 4, ra10, 2011; the permission was received from the 
journal.) 
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Figure 3-2.  (C) Inhibition of GSK-3 induces mTORC2 kinase activity. MDA-
MB-435 cells were incubated with BIO or SB-216763 as in Figure 3-2B under 
low-serum conditions. Rictor immunoprecipitates were used for in vitro kinase 
assays with full-length WT Akt1 as the substrate. (This figure was adopted from our 
previously published work in Sci. Signal. 4, ra10, 2011; the permission was received 
from the journal.) 
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3.3. The inhibitory regulation of mTORC2 and Akt by GSK-3 are conserved 
in Drosophila 
Alignment of rictor orthologs indicates that the first 1,000 amino acids of 
human rictor protein (total 1,708 amino acids) are highly conserved among 
eukaryotes (Sarbassov et al., 2004), and Ser-1235 residue is conserved in 
vertebrates (Figure 3-3A). Although the first 1,000 amino acids conserved region 
of human rictor sequence poorly aligns with the invertebrate Drosophila 
melanogaster rictor sequence, a small region within the adjacent sequence of 
human rictor Ser-1235 (from amino acids 1209 to 1238) does align with its 
Drosophila ortholog (from amino acids 1209 to 1237) with a potential 
phosphorylation site at Ser-1233 (Figure 3-3B). Thus, we reasoned that TORC2 
and Akt regulation by GSK-3 is possibly conserved in the Drosophila. To address 
this possibility, we performed GSK-3 inhibition in Drosophila S2 cells. Under low-
serum (1% FBS) condition, Drosophila Akt (dAkt) phosphorylation at the TORC2-
dependent Ser-505 residue (Sarbassov et al., 2005) increased after BIO 
treatment (Figure 3-3C). There is solely single gene in Drosophila encoding 
GSK-3. We knocked down this gene with double-stranded RNA (dsRNA)-
mediated RNA interference (RNAi) (Sarbassov et al., 2005). Knockdown of GSK-
3 promoted dAkt phosphorylation at Ser-505 (Figure 3-3D), implying that Akt 
activity was inhibited by GSK-3 in Drosophila cells. In addition, GSK-3 was 
required for declined dAkt Ser-505 phosphorylation under ER stress (Figure 3-
3E).  
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Figure 3-3.  The conservation of the rictor S-1235 site 
(A) The Ser-1235 site in rictor is conserved in vertebrates. Rictor vertebrate 
ortholog protein sequences were aligned with HomoloGene website 
(http://www.ncbi.nlm.nih.gov/homologene). 
(B) The alignment of human and Drosophila sequences within the area of the 
Ser-1235 site in human rictor.  
(These figures were adopted from our previously published work in Sci. Signal. 4, ra10, 
2011; the permission was received from the journal.) 
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Figure 3-3.  GSK-3-dependent regulation of Akt is conserved in the 
invertebrate fly Drosophila melanogaster 
(C) Similar to mammalian cells, Akt phosphorylation is increased by inhibition of 
GSK3 in Drosophila S2 cells. Drosophila S2 cells were incubated in 1% FBS 
containing Drosophila Schneider’s medium for 16 hours and then treated with 20 
μM BIO for 3 hours. 
(D) Knockdown of GSK3 in Drosophila S2 cells induces phosphorylation of Akt. 
GSK3 and GFP dsRNAs were transfected with Fugene 6 into S2 cells. After four 
days, S2 cells were collected and analyzed by Immunoblotting. 
(E) Phosphorylation of Akt in Drosophila S2 cells is regulated by ER stress. 
Drosophila S2 cells with or without GSK-3 knockdown were treated with 
thapsigargin (10 μM) for 24 hours.  
(These figures were adopted from our previously published work in Sci. Signal. 4, ra10, 
2011; the permission was received from the journal.) 
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3.4. GSK-3? is required for rictor phosphorylation at Ser-1235  
Our data demonstrated that ER stress-dependent rictor phosphorylation 
and mTORC2 inactivation is dependent on GSK-3 activity. In human, there are 
two structurally similar but functionally distinct GSK-3 isoforms: GSK-3? and 
GSK-3?. The selective GSK-3 inhibitors SB-216763 and BIO recognize the ATP-
binding pocket of GSK-3, which shares structural similarity in GSK-3? and GSK-
3?. Therefore, it is unlikely that GSK-3 inhibitors could discriminate between the 
two isoforms. To examine if both isoforms are required for rictor Ser-1235 
phosphorylation, we knocked down each isoform employing two different 
shRNAs specifically targeting GSK-3? or GSK-3?. Depletion of GSK-3? rather 
than GSK-3? prevented rictor Ser-1235 phosphorylation (Figure 3-4A).  
We further determined the role of GSK-3? in regulation of rictor 
phosphorylation and Akt signaling by using GSK-3?-deficient MEFs. Switching 
GSK-3? wild-type MEFs from high- to low-serum conditions caused raised rictor 
Ser-1235 phosphorylation, and this elevated phosphorylation was linked to 
reduced Akt Ser-473 phosphorylation (Figure 3-4B). By contrast, we did not 
observe the same effects in GSK-3?-null MEFs that were switched from high- to 
low-serum conditions (Figure 3-4B). Moreover, we analyzed the impact of ER 
stress to wild-type and GSK-3?-deficient MEFs. Wild-type MEFs displayed 
similar ER stress response as that of human cancer cells (Figure 3-2A); however, 
ER stress induction did not promote rictor  
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Figure 3-4.  GSK-3? is required for ER stress-induced phosphorylation of 
rictor at Ser-1235 and inhibition of Akt signaling. 
(A) Phosphorylation of rictor at Ser-1235 in cells requires GSK-3?. shRNAs 
targeting luciferase, GSK-3?, or GSK-3? were lentivirally transduced into MDA-
MB-435 cells. 
(B) Phosphorylation of rictor at Ser-1235 was not detected and phosphorylation 
of Akt at Ser-473 phosphorylation was increased in GSK-3?-null MEFs. GSK-
3?+/+ and GSK-3??/? MEFs were incubated with 10 or 1% FBS-containing 
medium for 16 hours.  
(These figures were adopted from our previously published work in Sci. Signal. 4, ra10, 
2011; the permission was received from the journal.) 
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phosphorylation at Ser-1235 or suppress Akt Ser-473 phosphorylation in GSK-
3?-deficient MEFs (Figure 3-4C). Previous findings showed that these two GSK-3 
isoforms have distinct functions (Hoeflich et al., 2000; Lee et al., 2007; Ruel et al., 
1993). Our results expanded the notion that GSK-3?, instead of GSK-3?, controls 
rictor Ser-1235 phosphorylation and inhibits Akt signaling in response to ER 
stress.  
 
3.5. GSK-3? phosphorylates Ser-1235 of rictor and inhibits mTORC2 kinase 
activity 
 Since GSK-3?-mediated rictor phosphorylation caused declining of the 
mTORC2 activity, we inferred that augment of GSK-3? protein level might also 
affect mTORC2 function. Certainly, overexpression of GSK-3? is effective to 
inhibit the kinase activity of mTORC2, which was linked to increased rictor 
phosphorylation at Ser-1235 (Figure 3-5A). Although rictor phosphorylation at 
Ser-1235 is dependent on the presence of GSK-3? and its activity, we could not 
make a conclusion that GSK-3? is the direct kinase of rictor. Thus, we further 
tested if GSK-3? could directly phosphorylate rictor by performing the in vitro 
GSK-3? kinase assay. Incubation of the immunopurified mTORC2 with or without 
active GSK-3? showed that GSK-3? directly phosphorylated Ser-1235 of rictor 
(Figure 3-5B). Following the in vitro GSK-3? kinase reaction, we applied the 
immunopurified mTORC2 for the kinase assay and found that its kinase activity 
decreased when rictor was phosphorylated by GSK-3? at Ser-1235 (Figure 3-
5B). Furthermore,  
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Figure 3-4.  GSK-3? is required for ER stress-induced phosphorylation of 
rictor at Ser-1235 and inhibition of Akt signaling. 
(C) GSK-3?-null MEFs show resistance to ER stress–dependent Akt inactivation. 
GSK-3?+/+ and GSK-3??/? MEFs were treated with tunicamycin (2 μg/ml) for 6 
hours. (This figure was adopted from our previously published work in Sci. Signal. 4, 
ra10, 2011; the permission was received from the journal.)  
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Figure 3-5.  GSK-3? phosphorylates rictor at Ser-1235 and inhibits 
phosphorylation of Akt by mTORC2. 
(A) GSK-3? overexpression enhances phosphorylation of rictor at Ser-1235 and 
inhibits phosphorylation of Akt by mTORC2. Rictor immunoprecipitates were 
prepared from lysates of COS-7 cells transfected with WT or mutant GSK-3? and 
used for in vitro kinase assays with full-length WT Akt1 as the substrate. (This 
figure was adopted from our previously published work in Sci. Signal. 4, ra10, 2011; the 
permission was received from the journal.) 
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Figure 3-5.  GSK-3? phosphorylates rictor at Ser-1235 and inhibits 
phosphorylation of Akt by mTORC2. 
(B) GSK-3? phosphorylates rictor at Ser-1235 and inhibits phosphorylation of Akt 
by mTORC2. GSK-3? was immunopurified from HEK 293T cells transfected with 
GSK-3?; cells were treated with tunicamycin (2 μg/ml) for 3 hours before harvest. 
Rictor immunoprecipitates were prepared from MDA-MB-435 cell lysates. The in 
vitro GSK-3? kinase assays were performed on rictor immunoprecipitates. As a 
control, GSK-3? was preincubated with 10 μM BIO before the kinase reaction. 
The in vitro mTORC2 kinase assays were subsequently performed on rictor 
immunoprecipitates. (This figure was adopted from our previously published work in 
Sci. Signal. 4, ra10, 2011; the permission was received from the journal.) 
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rictor phosphorylation was eliminated by inhibition of GSK-3, demonstrating that 
GSK-3?, but not a contaminating kinase, directly phosphorylated rictor at Ser-
1235. Therefore, GSK-3? inhibits mTORC2 kinase activity by directly 
phosphorylating rictor on Ser-1235.  
 
3.6. Blocking Ser-1235 phosphorylation of rictor prevents mTORC2 
inactivation by GSK-3?  
 We reasoned that if rictor Ser-1235 were the main regulatory site of GSK-
3?, mutation on this site would alter GSK-3?-dependent regulation of mTORC2 
function. We over-expressed either wild-type rictor or its Ser-1235 to Ala 
(S1235A) phospho-mutant that prevents phosphorylation in rictor-deficient MEFs. 
We detected higher Akt Ser-473 phosphorylation in the rictor S1235A mutant-
expressing MEFs in comparison with those expressing wild-type rictor (Figure 3-
6A). In addition, overexpression of GSK-3? led to decreased Akt Ser-473 
phosphorylation in the presence of wild-type rictor. On the contrary, mTORC2-
mediated Akt phosphorylation was not changed by overexpression of GSK-3? in 
the context of rictor S1235A mutant (Figure 3-6A). Thus, mutation of the rictor 
Ser-1235 is sufficient to prevent the mTORC2 inactivation by GSK-3?.  
Likewise, we observed more intense Akt Ser-473 phosphorylation in MEFs 
stably expressing the rictor S1235A in comparison with those expressing wild-
type rictor or the Ser-1235 to Aspartic acid (S1235D) mutant that mimics 
phosphorylation (Figure 3-6B). We further investigated ER stress responses in  
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Figure 3-6.  Blocking Ser-1235 phosphorylation of rictor prevents 
mTORC2 inactivation by GSK-3?. 
(A) GSK-3? inhibits Akt phosphorylation by phosphorylation of rictor at Ser-1235. 
Rictor-null MEFs grown in 10% serum were transfected with cDNAs encoding 
WT rictor or the S1235A mutant and with increasing amounts of GSK-3? cDNA. 
(This figure was adopted from our previously published work in Sci. Signal. 4, ra10, 2011; 
the permission was received from the journal.) 
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Figure 3-6.  Blocking Ser-1235 phosphorylation of rictor maintains higher 
mTORC2 activity. 
(B) Stable expression of the rictor S1235A phospho-mutant shows high basal 
phosphorylation of Akt that is insensitive to ER stress. Rictor-null MEFs 
constitutively expressing WT rictor or the phospho-mutants were treated with 
tunicamycin (0.3 μg/ml) for 8 hours. (This figure was adopted from our previously 
published work in Sci. Signal. 4, ra10, 2011; the permission was received from the 
journal.) 
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the MEFs restored with wild-type rictor or its phospho-mutants. Treatment of 
tunicamycin equally induced ER stress and GSK-3? activation in all cell lines 
(Figure 3-6B). However, Akt phosphorylation at Ser-473 did not decline under ER 
stress in the rictor S1235A-expressing MEFs (Figure 3-6B). This suggested that 
Ser-1235 of rictor is important for the GSK-3? impacts on mTORC2 and Akt 
signaling. Surprisingly, the S1235D mutant-expressing MEFs (which mimics 
constitutive rictor Ser-1235 phosphorylation) remained sensitive to ER stress at 
the level similar to that detected in the wild-type rictor-reconstituted MEFs. This 
inferred that ER stress suppresses Akt signaling not only by interfering with 
mTORC2 activity, but also by inhibiting upstream regulator of mTORC2 in the 
growth factor/PI3K signaling.  
 It is interesting that single rictor phosphorylation event can alter the activity 
of a huge protein complex (about 550 kD). Several possible mechanisms might 
be accountable for the impact of rictor Ser-1235 phosphorylation on mTORC2 
activity, such as destruction of complex integrity or interference of the substrate 
binding. To test which notion is correct, we first analyzed the integrity and activity 
of the mTORC2 reconstituting either wild-type rictor or its phospho-mutants. We 
observed similar amount of intact mTORC2 from MEFs expressing rictor wild 
type, S1235A, or S1235D-mutant (Figure 3-6C), suggesting that neither of the 
phospho-mutants changes the complex integrity of mTORC2. Consistently, 
kinase activity of the rictor S1235A-containing mTORC2 was higher than that of 
mTORC2 complexes restoring either wild-type rictor or S1235D mutant (Figure 3-
6C, upper panel). This scenario occurred in the complexes from the  
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Figure 3-6.  Blocking Ser-1235 phosphorylation of rictor maintains higher 
mTORC2 kinase activity. 
(C) Increased phosphorylation of Akt is observed with mTORC2 complexes 
containing the rictor S1235A mutant. Rictor immunoprecipitates from rictor-null 
MEFs stably expressing WT rictor or the phospho-mutants and grown in 10 or 
1% serum for 16 hours were used for in vitro kinase assays. (This figure was 
adopted from our previously published work in Sci. Signal. 4, ra10, 2011; the permission 
was received from the journal.) 
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high- or low-serum cell culture conditions. The data demonstrated that rictor Ser-
1235 phosphorylation regulates mTORC2 kinase activity, but not complex 
integrity.  
 
3.7. GSK-3?-mediated rictor phosphorylation at Ser-1235 hinders the 
mTORC2 substrate binding 
 Since rictor in conjunction with SIN1 regulates substrate specificity of 
mTORC2, the phosphorylation of rictor at Ser-1235 might affect the binding of 
Akt to mTORC2. To test this hypothesis, we developed the mTORC2 substrate-
binding assay in which the immunopurified mTORC2 was incubated with full 
length GST-Akt1 protein in the absence of ATP. Following incubation, the 
unbound proteins were thoroughly washed, and the protein level of GST-Akt 
bound to mTORC2 was analyzed by immunoblotting. First, we examined the 
interaction between mTORC2 and Akt in cells treated with tunicamycin or sorbitol 
(ER-stressed). We detected less GST-Akt protein bound to mTORC2 that was 
purified from ER stressed cells in comparison with control cells (Figure 3-7A). 
Therefore, ER stress causes deficient substrate binding ability of mTORC2, 
leading to mTORC2 inactivation. Given that ER stress-dependent mTORC2 
inactivation requires GSK-3?, GSK-3?-mediated rictor phosphorylation at Ser-
1235 may influence mTORC2 substrate binding. Accordingly, we further 
analyzed the impacts of the rictor phospho-mutantion on the Akt binding ability of 
mTORC2. The equal amount of mTORC2 purified from rictor wild  
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Figure 3-7.  Phosphorylation of rictor at Ser-1235 inhibits mTORC2 kinase 
activity by interfering with mTORC2 binding to Akt.  
(A) ER stress inhibits mTORC2 substrate binding. MDA-MB-435 cells were 
treated with tunicamycin or sorbitol (Sorb.) to induce stress. Rictor 
immunoprecipitates were used for the in vitro substrate binding assays with 
WTGST-Akt as the substrate and analyzed by immunoblotting. (This figure was 
adopted from our previously published work in Sci. Signal. 4, ra10, 2011; the permission 
was received from the journal.) 
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type, S1235A, or S1235D-mutant restored MEFs was employed for GST-Akt 
binding assay. The mTORC2 complex carrying wild-type rictor interacted with 
more GST-Akt compared to control (Figure 3-7B, left panel). In comparison with 
mTORC2 carrying wild-type rictor, the rictor S1235A phospho-mutant containing 
complex exhibited stronger GST-Akt binding ability; in contrast, the complex 
containing rictor S1235D phospho-mutant bound less amount of the substrate. 
The interaction of mTORC2 with its substrate was transient and dynamic since 
the binding was undetectable if ATP exists in the reaction buffer (Figure 3-7B, 
right panel). By contrast, when ATP is absent, the GST-Akt is inefficiently 
released from mTORC2. Under this setting, the bound GST-Akt protein amount 
represents the Akt-binding capacity of mTORC2. Therefore, these results 
demonstrated that the molecular mechanism of the mTORC2 inactivation caused 
by rictor Ser-1235 phosphorylation was due to interference of Akt binding to 
mTORC2. 
 
3.8. GSK-3?-mediated rictor phosphorylation at Ser-1235 controls cell 
proliferation and tumor growth 
 Our findings showed that GSK-3?-dependent rictor phosphorylation at 
Ser-1235 declines the mTORC2-Akt signaling. Since Akt controls cell 
proliferation, we inferred that rictor S1235A mutation may more strongly induce 
cell proliferation in comparison with wild-type rictor or the S1235D mutation. To 
test this possibility, we assessed the proliferation rate of these stable MEFs 
reconstituted with equal amount of the wild-type rictor and its phospho-mutants  
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Figure 3-7.  Phosphorylation of rictor at Ser-1235 inhibits mTORC2 kinase 
activity by interfering with mTORC2 binding to Akt. 
(B) Phosphorylation of rictor at Ser-1235 regulates mTORC2 substrate binding. 
Rictor immunoprecipitates from rictor-null MEFs stably expressing WT rictor or 
the phospho-mutants were used for the in vitro substrate binding assays with WT 
GST-Akt as the substrate. (This figure was adopted from our previously published 
work in Sci. Signal. 4, ra10, 2011; the permission was received from the journal.) 
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(Figure 3-8A, left panel). Restoration of the wild-type rictor into rictor-deficient 
MEFs augmented cell proliferation rate by 2.27 times. Restoration of the rictor 
S1235A mutant promoted cell proliferation more potently than the wild-type rictor 
(2.67 times in comparison with non-restored rictor-deficient MEFs and 30 % 
higher than rictor-WT restored MEFs). In contrast, MEFs restored with the rictor 
S1235D mutant displayed lower cell proliferation capacity (1.83 times related to 
non-restored rictor-deficient MEFs; 50 % less than rictor-WT restored MEFs) 
(Figure 3-8A, right panel). Notably, the cell proliferation rate of the rictor S1235A-
restored MEFs was twice higher than that of the rictor S1235D-restored MEFs. 
This finding indicates that GSK-3?-mediated rictor Ser-1235 phosphorylation is 
critical for controlling cell proliferation.  
 To expand our findings to the in vivo tumor xenograft system, we analyzed 
the impacts of rictor Ser-1235 phosphorylation on subcutaneous tumor growth. 
First, MEFs restored with rictor-WT or its phospho-mutants were transformed by 
overexpressing H-Ras (Figure 3-8B, left panel). Mice injected with the rictor 
S1235A-restored MEFs developed larger tumors in comparison with those 
injected with rictor-WT-restored MEFs (Figure 3-8B, right panel; Figure 3-8C). On 
the contrary, mice injected with MEFs containing the rictor S1235D mutation 
generated smaller tumors than those injected with either WT or S1235A rictor-
expressing MEFs (Figure 3-8B, right panel; Figure 3-8C). The data demonstrated 
that rictor Ser-1235 phosphorylation is significant for controlling cell proliferation 
and tumor growth.  
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Figure 3-8.  Phosphorylation of rictor at Ser-1235 inhibits cell proliferation.  
(A) WT rictor or the phospho-mutants were reintroduced into rictor-null MEFs 
with the lentiviral expression system. Cell proliferation measurements were 
performed by counting cells after 48 hours. The ratio of proliferation rate was 
graphed with GraphPad Prism 5 software. *P < 0.001 for all pair wise 
comparisons; one-way ANOVA, post hoc intergroup comparisons with Holm-
Sidat test. (This figure was adopted from our previously published work in Sci. Signal. 4, 
ra10, 2011; the permission was received from the journal.) 
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Figure 3-8.  Phosphorylation of rictor at Ser-1235 inhibits tumor growth. 
(B) MEFs described in Figure 3-7A were transformed by overexpression of the 
oncogenic form of H-Ras and injected into 6-week-old immunodeficient nude 
mice (n = 5 for each group; 5 ? 106 cells per mouse). Tumor size was measured 
after 15 days, the tumor sizes were calculated, and the volumes were presented 
by histogram. *One-way ANOVA, post hoc intergroup comparisons with Holm-
Sidat test; the P values are indicated. (C) Mice injected with MEFs expressing 
each form of rictor were killed and representative images of the excised tumors 
are shown. (These figures were adopted from our previously published work in Sci. 
Signal. 4, ra10, 2011; the permission was received from the journal.) 
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3.9. Discussion 
 Although ER stress is linked to inhibition of the Akt signaling in the 
pathogenesis of human diseases, the molecular mechanisms of how ER stress 
inhibits Akt signaling remain to be defined. In our study, we observed that ER 
stress induces GSK-3?-mediated rictor phosphorylation at Ser-1235, which 
suppresses mTORC2 kinase activity by impeding its substrate binding (Figure 3-
9). Our study provides a novel insight to fill the gaps of knowledge and clarifies 
the overlooked balance between two kinases, Akt and GSK-3?. Initially, GSK-3? 
has been identified as the substrate of Akt. Now, our study outlines the 
importance and mechanism that GSK-3?, the highly conserved and essential 
kinase in all eukaryotes, controls the anabolic growth factor signaling. This 
finding transforms GSK-3? from Akt substrate to the dominant stress-dependent 
regulator of Akt. It explains how ER stress inhibits growth factor signaling and 
how GSK-3? carries the tumor suppressive effect.  
In terms of GSK-3?-mediated phosphorylation, most GSK-3? substrates 
need priming phosphorylation at adjacent sites to promote the phosphorylation 
by GSK-3?. Nevertheless, several GSK-3? substrates do not require priming 
step, such as cyclin D1 and BCL3 (Diehl et al., 1998; Viatour et al., 2004). 
Besides, there is no serine residue at the adjacent priming site of rictor for prior 
phosphorylation. The resemblance of phosphorylation sites between rictor and 
BCL3 implies that priming phosphorylation is not required for GSK-3?-mediated 
rictor phosphorylation at Ser-1235. Our study also indicates that GSK-3?-  
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Figure 3-9.  The proposed working model for the first project. 
Initially, GSK-3? has been identified as the substrate of Akt. In my first project, 
we showed that under ER stress rictor is phosphorylated by GSK-3? at Ser-1235. 
This phosphorylation event causes inhibition of mTORC2 kinase activity by 
interfering with substrate binding. 
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mediated mTORC2 regulation is evolutionally conserved in vertebrates and 
invertebrate fly Drosophila melanogaster.   
In addition, our finding indicates that one specific Ser-1235 
phosphorylation on rictor inhibits Akt binding ability of the multi-protein complex 
(approximately 550 kDa). Other phosphorylation sites of rictor in proximity to Ser-
1235 including the Thr-1135 and Ser-1177 sites do not affect mTORC2 activity 
(Boulbes et al., 2010). Accordingly, we inferred that rictor Ser-1235 site locates in 
proximity to the Akt-binding pocket of mTORC2 and this phosphorylation event 
interrupts with Akt binding to mTORC2. In addition, rictor Ser-1235 
phosphorylation did not disrupt the complex integrity of mTORC2, indicating that 
Ser-1235 residue does not locate near the binding site of rictor to its interacting 
partners.  
Furthermore, previous mouse genetic models are consistent with our 
study in which GSK-3? obstructs the insulin-dependent Akt signaling, providing a 
link between GSK-3? and insulin resistance (Srinivasan et al., 2005; Tanabe et 
al., 2008). This explains why GSK-3 inhibitors act as the insulin-mimetic agents 
by stimulating glucose uptake and cell proliferation. GSK-3? becomes a 
promising target for treating multiple human diseases such as metabolic 
disorders (Cohen and Goedert, 2004; Rayasam et al., 2009). Hence, our finding 
connects clinical applications of GSK-3 inhibitors with activation of mTORC2/Akt 
signaling, and is particularly significant in development of these inhibitors for 
effective treatment of metabolic disorders. So far, most GSK-3 inhibitors could 
not distinguish between GSK-3? and GSK-3? because they are ATP competitive 
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inhibitors and the ATP binding sites of these two isoforms are very similar. To 
overcome the low specificity of this type of GSK-3 inhibitors, the development of 
the non-ATP competitive inhibitors (e.g. substrate competitive inhibitors) is very 
important. However, the substrate competitive inhibitors have a disadvantage 
that they usually bind weakly to the kinase (just like the dynamic substrate-
enzyme interaction). So, chemical modifications are required to improve the 
efficacy of the substrate competitive inhibitors by enhancing their binding affinity 
to GSK-3?.  
In our study, GSK-3? is highly activated under ER stress due to the 
observation that the phosphorylation of its substrate glycogen synthase (Ser-641) 
and auto-phosphorylation site (Tyr-216) (Chen et al., 2011). However, how ER 
stress controls GSK-3? activity remains scarcely characterized. It is important to 
address this question in the future. Our preliminary study also indicates that 
GSK3?-dependent rictor Ser-1235 phosphorylation is linked to a biphasic effect 
on mTORC2. As an immediate effect we observe inhibition of the mTORC2 
kinase activity, and as a long-term effect we detect an accelerated degradation of 
rictor. It is common that most of the known substrates of GSK3? are rapidly 
degraded by proteosomal pathway where GSK3?-mediated phosphorylation 
serves as a recognition motif for the ?-Trcp E3 ubiquitin ligase (Xu et al., 2009). It 
will be interesting to identify the mechanism for the Ser-1235 phosphorylation-
dependent rictor degradation.  
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Rationale 
The central component of the growth signaling mTOR assembles into two 
structurally and functionally different complexes (mTORC1 and mTORC2). The 
second complex, mTORC2, is a multi-protein kinase composed of mTOR, 
mLST8, SIN1 and rictor. In my last project (Chapter 3), we demonstrated that 
one specific rictor phosphorylation at Ser-1235 inhibits Akt binding of mTORC2. 
However, the regulatory mechanism of the mTORC2 complex integrity is not well 
characterized.  
In this study, I developed a reconstitution system of mTORC2 by co-
expression of its essential components (mTOR, mLST8, rictor, and SIN1), and 
observed that the mTOR-dependent SIN1 phosphorylation is critical for 
maintaining complex integrity by preventing SIN1 degradation. SIN1 is a critical 
component for mTORC2 complex formation and its kinase activity. Thus, I aimed 
to investigate the mechanism how mTOR kinase regulates integrity of mTORC2.  
 
Results 
4.1. The mTORC2 reconstitution by co-expression of its four components  
According to previous studies, mTORC2 components display distinct 
binding affinity (Frias et al., 2006; Sarbassov et al., 2004). A mild cell lysis buffer 
containing the CHAPS detergent could maintain the assembly of this kinase 
complex, whereas mTORC2 dissociates to two heterodimers (rictor/SIN1 and 
mTOR/mLST8) under stringent lysis condition with the Triton X-100 detergent. 
The biochemical studies suggest that the initial stage of the mTORC2 formation 
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is the dimerization of the mTOR/mLST8 and rictor/SIN1, respectively. Then, 
these two heterodimers assemble a relatively low affinity hetero-tetramer that is 
sensitive to the stringent lysis buffer containing Triton X-100.   
First, we tested the formation of the rictor/SIN1 heterodimer by co-
expressing rictor and SIN1. The V5-tagged SIN1 was co-transfected with the 
myc-tagged rictor, GCP2, or raptor cDNAs (Figure 4-1A, lower panel). 
Immunopurification via the myc antibody showed that SIN1 only bound to rictor 
rather than the control proteins GCP2 and raptor (Figure 4-1A, upper panel). 
Moreover, the interaction between rictor and SIN1 is required to stabilize mutual 
expression since SIN1 is highly unstable without its binding partner rictor (Frias 
et al., 2006). In order to reach the equivalent SIN1 expression, the five-fold 
amount of SIN1 cDNA was co-transfected with the control proteins GCP2 or 
raptor. Similarly, the co-expression of mTOR and mLST8 showed the formation 
of the mTOR/mLST8 heterodimer (Figure 4-1B). We observed that mTOR 
specifically interacted with mLST8 but not tubulin by pulling down myc-mTOR. 
Thus, the initial step of our reconstitution studies indicated the specific assembly 
of the rictor/SIN1 and mTOR/mLST8 heterodimers. 
Subsequently, we generated the reconstituted mTORC2 by co-expression 
of its four recombinant components (Figure 4-1C). After immunopurification of 
myc-mTOR, we analyzed its binding proteins and observed that SIN1 or rictor 
itself does not interact with mTOR/mLST8 heterodimer. We also detected low  
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Figure 4-1.  Reconstitution of the functional mTORC2 complex by 
expressing its recombinant components. 
(A) Rictor interacts with SIN1. SIN1-V5 plasmid DNA was co-transfected with 
myc-rictor into HEK-293T cells by Lipofectamine 2000, and cells were analyzed 
48 h following transfection. Cell lysates were applied for immunoprecipitation (IP) 
with anti-myc antibody. The immunoprecipitates and cell lysates were analyzed 
by immunoblotting with anti-myc and anti-V5 antibodies. 
(B) mTOR interacts with mLST8. Myc-mTOR construct was co-transfected with 
HA-mLST8 in HEK-293T cells. The negative control is presented by expressing 
HA-?-tubulin with myc-mTOR. (These figures were adopted from our previously 
published work in Journal of Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; 
the permission was received from the journal.) 
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Figure 4-1.  Reconstitution of the functional mTORC2 complex by 
expressing its recombinant components. 
(C) Interaction of mTOR with other mTORC2 components. The differently tagged 
recombinant components of mTORC2 were transiently expressed in HEK-293T 
cells, and the assembled complexes were purified by the immunoprecipitation of 
myc-mTOR. (This figure was adopted from our previously published work in Journal of 
Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; the permission was received 
from the journal.) 
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protein abundance of SIN1 and rictor alone because rictor/SIN1 heterodimer 
formation is required to stabilize their expression. Similarly, mTOR itself did not 
bind to rictor/SIN1 heterodimer, suggesting that the heterotrimer does not form 
during the mTORC2 assembly. When all four components of mTORC2 were co-
transfected, we observed the functional mTORC2 formation as shown by the in 
vitro mTORC2 kinase assay (Figure 4-1C). Our study of the mTORC2 
reconstitution system is consistent to the previous findings that SIN1, rictor and 
mLST8 are indispensable components for the assembly and function of 
mTORC2 (Frias et al., 2006; Guertin et al., 2006; Jacinto et al., 2006). 
Importantly, the endogenous mTORC2 components do not interfere with the 
recombinant mTORC2 reconstituted by transiently expressed mTOR, mLST8, 
rictor, and SIN1.   
We further examined if the reconstituted mTORC2 is regulated by growth 
factor signaling as the endogenous complex by analysis of its activity in growth 
factor responsive COS-7 cells (Roudabush et al., 2000). After co-transfection of 
the mTORC2 components, we stimulated the serum-starved COS-7 cells by IGF-
1 and immunopurified the reconstituted mTORC2 followed by the in vitro kinase 
reaction (Figure 4-1D). The mTORC2 purified from cells grown in 10% serum 
showed the low basal kinase activity and the complex from serum-starved cells 
did not exhibit kinase activity. In contrast, we observed the robust kinase activity 
of mTORC2 in IGF-stimulated cells. Thus, the reconstituted mTORC2 resembles 
its native form that is also controlled by growth factor signaling.   
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Figure 4-1.  Reconstituted mTORC2 kinase activity was stimulated by IGF-
1. (D) The differently tagged recombinant components of mTORC2 were 
transiently expressed in COS-7 cells, and the assembled complexes were 
purified by the immunoprecipitation of myc-mTOR. Lane 1, COS-7 cells 
expressing recombinant mTORC2 was cultured in growth medium containing 
10% serum. Lanes 2 and 3, COS-7 cells expressing recombinant mTORC2 were 
cultured in serum-free medium for 16 h and then treated without or with IGF-I 
(100 ng/ml) for 30 min, respectively. (This figure was adopted from our previously 
published work in Journal of Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; 
the permission was received from the journal.) 
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4.2. Reconstitution of mTORC2: The kinase activity of mTOR is required for 
Akt Ser-473 phosphorylation  
In the process of the growth factor-dependent Akt activation, the Ser-473 
phosphorylation is required to stabilize the active conformation of Akt (Pearce et 
al., 2010). Characterization of the Ser-473 kinase (PDK2) will provide a novel 
insight for the Akt regulation. Recent biochemical and mouse genetic studies 
clarified mTORC2 as the major Ser-473 kinase of Akt (Guertin et al., 2006; 
Jacinto et al., 2006; Sarbassov et al., 2005; Shiota et al., 2006; Yang et al., 2006). 
Although mTOR serves as the kinase within mTORC2, there was no direct 
evidence indicating mTOR as the Ser-473 kinase of Akt. In order to characterize 
the role of the mTOR kinase within mTORC2, we employed the reconstitution of 
mTORC2 carrying the kinase-dead form of mTOR. We co-transfected the cDNAs 
of the wild-type or kinase-dead mTOR with other essential mTORC2 components 
and analyzed the mTORC2 activity in the duplicate experiments. The mTORC2 
reconstituted with the kinase-dead mTOR did not exhibit kinase activity (Figure 4-
2A), indicating the essential role of the mTOR kinase domain for the kinase 
activity of mTORC2. Previous reports suggested that Akt auto-phosphorylation at 
Ser-473 occurs in regulation of Akt (Toker and Newton, 2000). To characterize 
the potential impact of Akt auto-phosphorylation, we performed the kinase 
reaction by using the kinase-inactive form of GST-Akt. The reconstituted wild-
type mTORC2 exhibited the robust kinase activity toward the kinase-inactive 
form of GST-Akt, demonstrating that Akt auto-phosphorylation does not take 
place during the mTORC2-mediated Akt phosphorylation (Figure 4-2A).  
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Figure 4-2.  Critical role of mTOR kinase activity in mTORC2 function. 
(A) The kinase-dead mTOR forms inactive mTORC2 and causes deficiency in 
assembly of the complex. The study has been performed in duplicate: Xpress-
rictor, SIN1-V5, and HA-mLST8 constructs were co-transfected with myc-mTOR 
wild type (WT) (lanes 1 and 2) or myc-mTOR kinase-dead (KD) (lanes 3 and 4) in 
HEK-293T cells. Immunoprecipitates (IP) prepared with anti-myc antibody were 
used for the in vitro kinase assay with wild-type or kinase-dead Akt as the 
substrate. (This figure was adopted from our previously published work in Journal of 
Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; the permission was received 
from the journal.) 
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In the subsequent analysis, we found that the kinase-dead mTOR did not 
interrupt expression and interaction with its binding partner mLST8; however, it 
resulted in the declined expression of rictor and SIN1, which led to ineffective 
formation of the mTORC2 (Figure 4-2A). In addition, SIN1 protein displayed the 
slower migratory form in the complex with wild-type mTOR rather than kinase-
dead mTOR (Figure 4-2A). This indicated that mTOR kinase activity might be 
required for SIN1 protein modification, which is linked to regulation of SIN1 
protein stability.  The experiment in Figure 4-2A showed that the kinase-dead 
mTOR caused a profound impact on the rictor and SIN1 expression that resulted 
in low abundance of mTORC2. To overcome the uneven mTORC2 assembly, we 
optimized the formation of the complex with wild-type mTOR by co-expressing 
only 30 % of the SIN1 cDNA (Figure 4-2B). The comparable amounts of the 
immunopurified mTORC2 complexes assembled with mTOR-WT or mTOR-KD 
were applied for in vitro kinase assay. Contrary to mTOR-WT, the mTORC2 
reconstituted with kinase-dead mTOR again did not exhibit the kinase activity. 
Similarly, the SIN1 co-expressed with mTOR-WT showed the slower mobility in 
the gel, indicating that SIN1 protein modification is dependent on mTOR kinase 
activity. Collectively, our analysis showed that mTOR kinase within mTORC2 is 
required for mTORC2 function as the Akt Ser-473 kinase, and also contributes to 
the regulation of SIN1 through protein modification.  
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Figure 4-2.  Critical role of mTOR kinase activity in mTORC2 function. 
(B) The study similar to that in Figure 4-2A was performed by optimizing 
expression and assembly of the mTORC2 assembled with the wild-type or the 
kinase-dead mutant of mTOR. To optimize expression, the myc-mTOR-WT was 
co-transfected with Xpress-rictor, 30% of SIN1-V5, and HA-mLST8 constructs in 
HEK-293T cells (lanes 1 and 2). (This figure was adopted from our previously 
published work in Journal of Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; 
the permission was received from the journal.) 
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4.3. Phosphorylation of SIN1 occurs upon assembling into mTORC2 
complex in vitro 
Our data shown in Figure 4-2 indicate that SIN1 protein abundance and its 
modification depend on the mTOR kinase activity. Most likely, the observed SIN1 
protein modification is caused by phosphorylation. To test this possibility, we 
reconstituted and purified mTORC2 followed by phosphatase treatment (Figure 
4-3A). Only the active form of phosphatase changed the SIN1 mobility from the 
slower to faster migratory form, suggesting that SIN1 is phosphorylated within 
mTORC2 assembled with wild-type mTOR.  
To further investigate if SIN1 is the mTOR substrate, we examined the 
mTOR-mediated SIN1 phosphorylation by the in vitro mTORC2 assembly. First, 
we purified the co-expressed FLAG-mLST8/myc-mTOR heterodimer by FLAG 
peptide elution. Then, the immunopurified myc-rictor/V5-SIN1 heterodimer bound 
to protein G-agarose beads was incubated with soluble FLAG-mLST8/myc-
mTOR heterodimer. After co-incubation, the protein G-agarose beads were 
thoroughly washed and analyzed for the complex formation and kinase activity of 
mTORC2. Indeed, these two heterodimers have integrated to mTORC2 as 
shown by its four components (Figure 4-3B). The in vitro assembled mTORC2 
exhibited kinase activity toward Akt Ser-473. In addition, SIN1 protein changed 
mobility to the slower migratory form following in vitro mTORC2 reconstitution 
(Figure 4-3B), resembling its phosphorylated form before phosphatase treatment 
(Figure 4-3A). These results indicated that SIN1 is the mTOR substrate.  
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Figure 4-3.  SIN1 is a substrate of mTOR. 
(A) SIN1 as a component of mTORC2 is a phospho-protein. Myc-mTOR-WT 
cDNA was co-transfected with Xpress-rictor, Sin1-V5, and HA-mLST8 cDNAs in 
HEK-293T cells. Cell lysates were applied for immunoprecipitation with anti-V5 
antibody. The immunoprecipitates were incubated with or without calf intestinal 
phosphatase (CIP) or inactive CIP (pretreated with 50 mM EDTA). CIP treatment 
resulted in a faster migratory form of SIN1, suggesting that the mobility shift of 
SIN1 band is indeed due to phosphorylation/dephosphorylation. (This figure was 
adopted from our previously published work in Journal of Biological Chemistry Vol. 286, 
No. 46, 40386-40394, 2011; the permission was received from the journal.) 
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Figure 4-3.  SIN1 is a substrate of mTOR. 
(B) SIN1 as a component of mTORC2 is a substrate of mTOR. In vitro mTORC2 
kinase assay was performed by incubation of two heterodimers, rictor/SIN1 and 
mTOR/mLST8. First, FLAG purification was conducted from HEK-293T cells with 
FLAG-mLST/myc-mTOR co-transfection. Then, the purified soluble FLAG-
mLST/myc-mTOR heterodimer was incubated with immunopurified myc 
rictor/SIN1-V5 by the V5 antibody at room temperature for 2 h in mTORC2 
kinase buffer with 1 mM ATP. After washing three times with 0.3% CHAPS lysis 
buffer, the immunoprecipitates were used for the in vitro mTORC2 kinase 
reaction by using wild-type Akt as the substrate. (This figure was adopted from our 
previously published work in Journal of Biological Chemistry Vol. 286, No. 46, 40386-
40394, 2011; the permission was received from the journal.) 
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4.4. The lysosomal degradation of SIN1 protein is caused by the inactive 
mTOR kinase  
Our data suggested that SIN1 protein expression is dependent on the 
mTOR-mediated SIN1 phosphorylation. To further inspect the regulation of SIN1 
by mTOR kinase, we studied SIN1 protein half-life by the inhibition of protein 
synthesis. As described in Figure 4-2B, we normalized the reconstituted 
mTORC2 by reducing SIN1 expression with wild-type mTOR. Following 
cycloheximide treatment, we detected the shorter SIN1 protein half-life in the 
mTOR-KD co-expression (Figure 4-4A), suggesting that declined SIN1 protein 
level results from accelerated protein degradation. The quantification of the 
immunoblotting image of SIN1 displayed the greater effect of mTOR-KD on 
diminishing the SIN1 half-life approximately eight times in comparison with 
mTOR-WT (Figure 4-4B).  
The ubiquitin-proteasomal and lysosomal degradation are two major 
representatives of protein degradation pathways. To verify which pathway 
regulates SIN1 protein degradation, we reconstituted mTORC2 with the mTOR-
KD form in cells and studied effects of MG132 (proteasome inhibitor) or 
chloroquine (lysosome inhibitor). The Skp2-mediated proteasomal pathway is 
required for the degradation of the cell cycle regulator p27 protein (Carrano et al., 
1999). We observed the considerable increase of the p27 protein after MG132 
treatment (Figure 4-4C) revealing that the drug was effective in inhibition of the 
proteosomal pathway. However, the suppression of the proteosomal pathway did 
not block SIN1 degradation as shown by the low SIN1 protein amount in the  
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Figure 4-4.  mTOR kinase activity stabilizes SIN1 by preventing its 
lysosomal degradation. 
(A) Optimized reconstitution of mTORC2 by co-expression of its components was 
performed as in Figure 4-2B. 48 h following transfection, cells were treated with 
20 μg/ml cycloheximide and lysed at the indicated time points. (This figure was 
adopted from our previously published work in Journal of Biological Chemistry Vol. 286, 
No. 46, 40386-40394, 2011; the permission was received from the journal.) 
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Figure 4-4.  mTOR kinase activity stabilizes SIN1 by preventing its 
lysosomal degradation. 
(B) Graphic represents mTOR kinase-dependent SIN1 half-life shown in (A). 
SIN1-V5 signals were quantified by GelPro 4.5 software. The half-life of SIN1 co-
expressed with mTOR-WT is shown as filled circles, and its half-life when co-
expressed with mTOR-KD is shown as open circles. (This figure was adopted from 
our previously published work in Journal of Biological Chemistry Vol. 286, No. 46, 
40386-40394, 2011; the permission was received from the journal.) 
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Figure 4-4.  mTOR kinase activity stabilizes SIN1 by preventing its 
lysosomal degradation. 
(C) myc-mTOR-KD or its wild-type construct was co-transfected with Xpress-
rictor, SIN1-V5, and HA-mLST8 constructs into HEK-293T cells. After 48-h 
transfection, cells were treated with 30 μM MG132 or 100 μM chloroquine and 
collected at the indicated time points. (This figure was adopted from our previously 
published work in Journal of Biological Chemistry Vol. 286, No. 46, 40386-40394, 2011; 
the permission was received from the journal.) 
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presence or absence of MG132. Only the lysosomal inhibitor chloroquine led to 
elevated SIN1 protein level comparable to that in the co-expression of the wild-
type mTOR (Figure 4-4C). Thus, these results demonstrated that SIN1 
degradation caused by deficient mTOR kinase is dependent on lysosomal 
degradation pathway.  
 
4.5. Endogenous SIN1 protein level depends on mTOR expression and its 
kinase activity 
 Our findings based on the recombinant mTORC2 reconstitution system 
indicated that protein stability of SIN1 depends on mTOR kinase activity. To 
confirm our results, we validated if mTOR regulates the endogenous SIN1 
protein. Indeed, the knockdown of mTOR by expressing specific shRNAs led to 
the declined protein amount of the endogenous SIN1 (Figure 4-5A). This 
negative impact correlates well with the mTOR knockdown efficiency since the 
smaller SIN1 protein amount is observed in cells containing the shRNA#2, which 
causes the stronger suppressive effect on the mTOR protein level. 
 Next, we addressed if mTOR inhibition is able to mimic the impact on 
SIN1 protein stability by mTOR-KD. We applied the highly specific mTOR 
inhibitor TORIN in MDA-MB-435 cells (Liu et al., 2010; Thoreen et al., 2009), 
which resulted in a potent mTOR inactivation as shown by the de-
phosphorylation of the mTORC2 substrate Akt (Ser-473 and Thr-450) and the 
mTORC1 substrate S6K1 (Thr-389) (Figure 4-5B). TORIN also inhibited the 
mTOR auto-phosphorylation at Ser-2481 (Peterson et al., 2000). By contrast, the  
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Figure 4-5.  Endogenous SIN1 expression is dependent on mTOR kinase 
activity.  
(A) SIN1 protein abundance decreased with a loss of mTOR. The mTOR 
knockdown has been performed by the lentiviral expression of two shRNAs in 
HeLa cells. A nonspecific luciferase shRNA was used as a control. (This figure 
was adopted from our previously published work in Journal of Biological Chemistry Vol. 
286, No. 46, 40386-40394, 2011; the permission was received from the journal.) 
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Figure 4-5.  Endogenous SIN1 expression is dependent on mTOR kinase 
activity.  
(B) mTOR kinase activity controls abundance of SIN1. MDA-MB-435 cells were 
incubated with specific mTOR inhibitor (0.5 μM TORIN) for 24 or 48 h. (This figure 
was adopted from our previously published work in Journal of Biological Chemistry Vol. 
286, No. 46, 40386-40394, 2011; the permission was received from the journal.) 
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PDK1-dependent Akt phosphorylation at Thr-308 has been stimulated by the 
mTOR kinase inactivation, which is consistent to the previous report (Peterson et 
al., 2009). This outcome is likely due to the compensatory effect caused by the 
mTORC2-dependent inhibition of Akt. Notably, the prolonged mTOR inhibition by 
TORIN led to a considerable reduction of the endogenous SIN1 protein level 
(Figure 4-5B). Therefore, our results demonstrate that mTOR and its kinase 
activity is required for protein expression of SIN1 within either endogenous or 
reconstituted mTORC2.  
 
4.6. SIN1 protein abundance and mTORC2 integrity is regulated by the 
amount of cellular glucose 
 Previous research suggested that nutrient signals positively regulate 
mTOR activity. In the absence of the amino acids in cells, it showed strong 
reduction of the mTORC1 activity. Moreover, AMPK negatively regulates 
mTORC1/S6K activity under energy deprivation. However, how mTORC2 
responds to the nutrient or energy depletion is still unclear. According to our 
study of the mTORC2 reconstitution, the mTOR kinase activity is required for 
maintaining SIN1 protein stability and integrity of mTORC2. To identify the 
physiological conditions that cause mTOR dysfunction and SIN1 degradation, we 
studied the metabolic stress conditions in cells. Glucose is the essential energy 
source for cells to produce ATP; amino acids are the key elements for protein 
synthesis. MDA-MB-435 and HeLa cells were incubated in mediums without 
glucose or amino acids for 20 hours (Figure 4-6A).  
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Figure 4-6.  Glucose starvation, but not amino acid deprivation, causes 
rictor and SIN1 protein degradation and mTORC2 dissociation.  
(A) Decreased SIN1 and rictor protein abundance under glucose starvation is 
associated with reduced basal mTORC2 activity toward Akt Thr-450. MDA-MB-
435 and HeLa cells were incubated with glucose-free or amino acid-free 
mediums for 20 hours, respectively. Immunoblotting was used to detect 
phosphorylation of Akt at Thr-450 and the amount of the indicated proteins in the 
cell lysates.  
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Prolonged glucose starvation led to SIN1 degradation and inhibited 
phosphorylation of Akt at Thr-450, which is a well-characterized constitutive 
phosphorylation site of mTORC2 (Facchinetti et al., 2008; Ikenoue et al., 2008). 
Because rictor stability requires its binding to SIN1, we detected rictor 
degradation due to less SIN1 protein abundance after glucose depletion. In 
contrast, we did not have the similar observation from cells cultured in amino 
acid-free medium.  
SIN1 is an essential component of mTORC2 and required for complex 
formation. By pulling down mTOR from cells under glucose starvation at the 
shorter time point (16 hours), we found that SIN1 and rictor did not bind mTOR 
efficiently (Figure 4-6B). Under this setting, the dissociation of raptor from mTOR 
was associated with the elevated AMPK-dependent raptor phosphorylation at 
Ser-792. It suggests that AMPK might play a role in the regulation of mTORC1 
assembly. The above results indicated that integrity of mTORC2 and mTORC1 is 
sensitive to glucose depletion, but not amino acid starvation.  
 
4.7. The mTOR Kinase functions as the ATP sensing component of 
mTORC2 
 Why glucose deprivation causes mTORC2 inactivation, dissociation and 
SIN1 degradation? Glucose is the essential source for generating ATP. We 
measured ATP level from cells under glucose starvation and found that cellular 
ATP ratio gradually decreased in the time-dependent manner (Figure 4-7A). 
Previous study showed that mTOR has lower ATP binding ability and is a  
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Figure 4-6.  Glucose starvation, but not amino acid deprivation, causes 
rictor and SIN1 protein degradation and mTORC2 dissociation. 
(B) Deficient complex integrity of the mTORC1 and mTORC2 is caused by 
glucose deprivation. MDA-MB-435 cells were incubated with glucose-free 
medium for 10, 16 and 20 hours or amino acid-free medium for 20 hours, 
respectively. The mTOR immunoprecipitates were prepared from cell lysates to 
examine the complex formation of the mTORC1 and mTORC2.  
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Figure 4-7.  Cellular ATP ratio gradually decreases under glucose 
starvation condition with the time-dependent manner. 
(A) MDA-MB-435 cells were incubated with glucose-free medium for 0, 3, 6, 9, 12 
and 15 hours, and collected for quantitative detection of ATP by luciferase driven 
bioluminescence assay (Roche ATP Bioluminescence Assay Kit CLS II). Three 
independent experiments were shown for each condition.  
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homeostatic ATP sensor (Dennis et al., 2001). Thus, a cellular ATP level may 
directly affect mTOR kinase activity. To prove this, we immunopurified mTORC2 
and analyzed the in vitro mTORC2 kinase activity toward Akt under different ATP 
concentrations (Figure 4-7B). We detected the highest kinase activity of 
mTORC2 at the concentration of ATP above the 1.2 mM range, whereas most 
protein kinases require about 0.1 mM ATP for full activation (Dennis et al., 2001). 
Using the same ATP titration conditions for mTORC1, we obtained similar results 
for Thr-389 phosphorylation of S6K1 by mTORC1 purified by raptor 
immunoprecipitation (Figure 4-7C). These findings support the role of mTOR 
kinase as the ATP sensor. We also interpret that mTORC2 kinase activity 
declined under glucose starvation is mediated by ATP depletion. Since SIN1 
protein stability depends on its phosphorylation by mTOR, the mTORC2 kinase 
activity highly sensitive to the ATP depletion under glucose starvation led to SIN1 
degradation and complex dissociation. 
    
4.8. Phosphorylation of SIN1 at Ser-260 is dependent on the ATP-sensitive 
mTORC2 activity 
 To further characterize the mTOR-dependent regulation of SIN1, we 
attempted to identify SIN1 phosphorylation site. We applied the mTORC2 
reconstitution system by co-expressing wild type mTOR or its kinase-dead form 
with other three essential components (Xp-rictor, V5-SIN1 and HA-mLST8). By 
pulling down V5-SIN1, the enriched samples from 10 immunoprecipitates were 
applied for SDS-PAGE and Commassie Blue staining (Figure 4-8A). Mass  
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Figure 4-7.  The activity of the mTOR kinase complexes is sensitive to 
ATP concentration.  
(B) For mTORC2 kinase reaction, rictor immunoprecipitates prepared from 
lysates of MDA-MB-435 cells were used for in vitro kinase assays with full-length 
WT-Akt1 as the substrate and different amount of the ATP (0, 0.1, 0.2, 0.4, 0.6, 
0.8, 1.2, 1.6, and 3.2 mM, respectively). 
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Figure 4-7.  The activity of the mTOR kinase complexes is sensitive to 
ATP concentration.  
(C) For mTORC1 kinase reaction, raptor immunoprecipitates prepared from 
lysates of MDA-MB-435 cells were used for in vitro kinase assays with full-length 
WT-S6K1 as the substrate and different amount of the ATP (0, 0.1, 0.2, 0.4, 0.6, 
0.8, 1.2, 1.6, and 3.2 mM, respectively). Both kinase complexes require at least 
1.2 mM ATP for full kinase activity. 
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Figure 4-8.  Identification of the mTOR-dependent SIN1 phosphorylation 
site. 
(A) Xpress-rictor, SIN1-V5, and HA-mLST8 constructs were cotransfected with 
Myc-mTOR (wt) or Myc-mTOR (KD) in HEK-293T cells, respectively. 
Immunoprecipitates prepared from lysates of HEK-293T cells with anti-V5 
antibody were resolved in SDS-PAGE and visualized by Coomassie blue staining. 
The potential SIN1 gel bands were excised and sent for Mass spectrometric 
analysis.
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spectrometric analysis was then carried out to determine the potential SIN1 
phosphorylation site. Based on the mass spectrometry readings of the distinct 
SIN1 peptides, Ser-260 has been verified with a high probability as the SIN1 
phosphorylation site (Figure 4-8B).  
To study the role of this SIN1 phosphorylation site, the anti-SIN1 (Ser-260) 
antibody has been generated. The specificity of this antibody was validated by 
examining its interaction to the wild type SIN1 or its phospho-mutant (S260A). 
The phospho-SIN1 (Ser-260) antibody did not recognize its mutated epitope and 
exhibited high specificity (Figure 4-8C). We applied this specific phospho-SIN1 
(Ser-260) antibody to analyze the SIN1 phosphorylation in response to glucose 
deprivation. We observed that phosphorylation of SIN1 at Ser-260 decreased 
after glucose starvation for 16 hours, but not at amino acid deprivation condition 
(Figure 4-8D). In this setting, we also detected the disassembly of mTORC2 after 
16 hours glucose depletion (Figure 4-6B). Thus, phosphorylation of SIN1 Ser-260 
may play an important role for maintaining mTORC2 integrity.  
We analyzed the SIN1 protein sequence and found that Ser-260 is located 
within the highly conserved region, which was designated as the Box1 (residues 
225–267 of the human SIN1 sequence; Figure 4-8E). Box1 lays within the larger 
region of unknown function referred as the Conserved Region In the Middle 
(CRIM), a highly conserved domain (residues 140–267). It suggests that the Ser-
260 phosphorylation site within CRIM is critical for SIN1 stability. On the other 
hand, mTOR is known to prefer to phosphorylate serine  
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Figure 4-8.  Identification of the mTOR-dependent SIN1 phosphorylation 
site 
(B) Phosphorylation of Ser-260 in SIN1 identified by MS/MS. SDS-PAGE 
purification followed by enzymatic digestion and LC/MS/MS was used to isolate 
peptide containing phosphorylated serine residue in position 4 (S*). Expected 
masses for the y and b ions are listed above and below the peptide sequence. 
Ions that were positively identified are highlighted in blue and red. Y ions at 940.5 
and 773.5 define the phospho-serine residue at position 4. The abundant ion at 
597.5 is the neutral loss of 98 Da from the doubly charged parent ion.  
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Figure 4-8.  
(C) Cross validation of the p-SIN1 (Ser-260) antibody. The V5 tagged wild type or 
SIN1 Ser-260A phospho-mutant was expressed in HEK-293T cells and 
immunopurified using V5 antibody. The immunopurified wild type and phospho-
mutant SIN1 proteins were analyzed by western blotting with the phospho-SIN1 
(S260) and V5 antibodies. 
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Figure 4-8. 
(D) Glucose starvation results in dephosphorylation of SIN1 Ser-260 in MDA-MB-
435 cells. MDA-MB-435 cells were incubated in plus or minus glucose medium 
for 10 and 16 hours. The cells were also incubated in 10 % serum medium or 
amino acid-free medium for 16 hours as controls. The SIN1 protein was 
immunopurified with anti-SIN1 antibody. The dephosphorylation of the 
endogenous SIN1 in MDA-MB-435 cells occurs after 16 hours of glucose 
starvation. 
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Figure 4-8. 
(E) SIN1 protein domains: CRIM: conserved region in the middle; RBD: Raf-like 
Ras-binding domain; PH: pleckstrin homology. Box1 (amino acids 225-267) is the 
highly conserved region located within the CRIM domain. mTOR kinase-
dependent SIN1 site (Ser-260) resides in the Box1, implying the significant role 
of this phosphorylation site. The Serine residue of SIN1 and the known mTORC2 
substrates: Akt, SGK1 and PKC? are surrounded by hydrophobic amino acids.  
* indicates the hydrophobic amino acids. 
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residues within the hydrophobic motif. For instance, the well-studied mTORC2 
substrates: Akt Ser-473, SGK1 Ser-422 and PKC? Ser-657 are located in the 
regions containing hydrophobic amino acids. The SIN1 Ser-260 site also 
represents the hydrophobic motif suggesting that mTOR might be a potential 
kinase of this site (Figure 4-8E).  
To prove that mTOR is the SIN1 Ser-260 kinase, we studied the SIN1 
phosphorylation by the in vitro mTORC2 reconstitution as described in Figure 4-
3B. After co-incubation of the FLAG-mLST8/myc-mTOR and myc-rictor/V5-SIN1, 
these two heterodimers have assembled into functional mTORC2. Also, the 
increased SIN1 Ser-260 phosphorylation after mTORC2 assembly indicated that 
SIN1 is the substrate of mTOR kinase (Figure 4-8F). 
 
4.9. The SIN1 Ser-260 site is ATP dependent and regulates SIN1 
degradation and mTORC2 assembly  
 We have shown that the ATP depletion by the prolonged glucose 
starvation led to SIN1 dephosphorylation and its degradation. To test other 
physiological conditions that cause ATP depletion, we treated the MDA-MB-435 
cells with 5 mM 2-DG and 10 μM rotenone in the time-dependent manner and 
found that SIN1 degradation occurred after 2 hours of drugs treatment (Figure 4-
9A). We applied the lysates from cells with 1 hour drugs treatment for SIN1 
immunoprecipitation and observed the decreased SIN1 Ser-260 phosphorylation 
and the disassembly of the mTORC2 (Figure 4-9B). In this condition, the 
treatment of 2-DG and rotenone led to acute ATP depletion (White et al., 2002)  
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Figure 4-8.  mTOR is the kinase for SIN1 Ser-260 phosphorylation. 
(F) In vitro mTORC2 assembly was performed by incubation of two heterodimers, 
rictor/Sin1 and mTOR/mLST8 as mentioned in Figure 4-3B. The result showed 
the in vitro assembly of two heterodimers (rictor/Sin1 and mTOR/mLST8) and 
direct phosphorylation of SIN1 (slower migratory form and detection of the 
phospho-SIN1 S260 signal) by mTOR. The in vitro assembled mTORC2 is a 
functional complex that contains the kinase activity toward Akt and SIN1. 
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Figure 4-9.  ATP depletion causes dephosphorylation of SIN1 Ser-260, 
mTORC2 complex dissociation, and SIN1 degradation. 
(A) Acute ATP depletion leads to decreased SIN1 protein abundance. MDA-MB-
435 cells were incubated with 5 mM 2-DG and 10 μM rotenone in glucose-free 
medium for 1, 1.5 and 2 hours. 
(B) Acute ATP depletion leads to dephosphorylation of SIN1 Ser-260 and 
mTORC2 complex dissociation. MDA-MB-435 cells were incubated with 5 mM 2-
DG and 10 μM rotenone in glucose-free medium for 1 hour. The SIN1 
immunoprecipitates were prepared from cell lysates to examine the complex 
formation of the mTORC2. 
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and similar effects on mTORC2 that is caused by prolonged glucose starvation. 
These results indicate that the acute ATP-depletion is sufficient to cause 
dephosphorylation of SIN1 on Ser-260, SIN1 degradation, and deficiency of the 
mTORC2 integrity. 
 
4.10. The mTOR-dependent phosphorylation of SIN1 at Ser-260 regulates 
SIN1 protein stability and maintains mTORC2 integrity 
 We hypothesized if Ser-260 in SIN1 is the main regulatory residue in the 
mTORC2 complex, mutation of this residue will alter SIN1 protein stability and 
mTORC2 integrity. We generated the SIN1 phospho-mutants by substituting the 
Ser-260 to alanine (S260A that prevents phosphorylation) or aspartic acid 
(S260D that mimics phosphorylation), and applied the mutant constructs to the 
mTORC2 reconstitution system. In the cotransfection with mTOR-WT, the SIN1 
(S260A) mutant showed less protein abundance compared to wild-type SIN1 and 
S260D mutant (Figure 4-10A). In the co-expression with mTOR-KD, wild-type 
SIN1 that failed to be phosphorylated by functional mTOR kinase displayed low 
protein abundance, similar to the S260A mutant. However, S260D mutant of 
SIN1 that mimics the mTOR-dependent phosphorylation remained insensitive to 
the mTOR kinase activity (Figure 4-10A).  
To further analyze mTORC2 assembly, we optimized SIN1 expression by 
co-expressing distinct amount of the cDNAs encoding wild-type SIN1 and its 
phospho-mutants (Figure 4-10B). To optimize expression of the unstable S260A 
mutant, we co-transfected with mTOR-WT only 30 % amount of the cDNAs  
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Figure 4-10.  SIN1 Ser-260 phosphorylation is required for its protein 
stability. 
(A) The V5 tagged wild type or phospho-specific SIN1 recombinant proteins 
(S260D and S260A) were co-expressed with myc-mTOR (wt) or myc-mTOR (KD), 
respectively, and another two mTORC2 components (Xp-rictor and HA-mLST8) 
in HEK-293T cells. The total cell lysates and immunoprecipitates purified using 
Myc antibody was analyzed by western blotting with the indicated tag antibodies.
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Figure 4-10.  SIN1 Ser-260 phosphorylation is required for mTORC2 
complex integrity 
(B) The V5 tagged wild type or phospho-specific SIN1 recombinant proteins 
(S260D and S260A) were co-expressed with myc-mTOR (wt) or myc-mTOR (KD), 
respectively, and another two mTORC2 components (Xp-rictor and HA-mLST8) 
in HEK-293T cells. To optimize the SIN1 expression, the myc-mTOR-WT was co-
transfected with 30 % of V5-SIN1-WT, 30 % of V5-SIN1-S260D or 100 % of V5-
SIN1-S260A. The myc-mTOR-KD was co-transfected with 100 % of V5-SIN1-WT, 
30 % of V5-SIN1-S260D or 100 % of V5-SIN1-S260A. The myc 
immunoprecipitates were prepared from cell lysates to examine the complex 
integrity of the mTORC2. 
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encoding wild-type SIN1 and S260D mutant. The immunoprecipitates with the 
comparable abundance of mTORC2 reconstituted with wild-type SIN1 or its 
phospho-mutants showed that SIN1 S260A mutant was not effective to form 
mTORC2. This suggested that phosphorylation of SIN1 at Ser-260 is required to 
retain complex integrity. In the cotransfection with mTOR-KD, only 30 % of the 
cDNA encoding SIN1 S260D mutant was co-expressed. Under this setting, wild-
type SIN1 that was unable to be phosphorylated by functional mTOR kinase was 
incapable to assemble mTORC2, similar to the SIN1 S260A mutant (Figure 4-
10B). In contrast, the SIN1 S260D mutant that mimics phosphorylation could 
prevent complex dissociation and still remained in the complex with the kinase 
dead mTOR. Collectively, the mTOR kinase-dependent phosphorylation of SIN1 
at Ser-260 preserved the complex integrity of mTORC2 by stabilizing SIN1. 
 
4.11. The mTOR-dependent phosphorylation of SIN1 at Ser-260 regulates 
cell proliferation  
 To further examine the biological impact of the mTOR-mediated SIN1 
phosphorylation at Ser-260, we generated the stable MEFs by restoring similar 
amounts of SIN1-WT and its phospho-mutants into SIN1-deficient MEFs. We 
detected a higher basal Akt Ser-473 phosphorylation in SIN1 S260D mutant-
restored stable MEF compared to those restored with SIN1-WT or S260A mutant 
(Figure 4-11A). We analyzed the complex integrity of mTORC2 in these stable 
MEFs by SIN1 immunoprecipitation and found that SIN1 S260D mutant is more 
effective in assembling mTORC2 compared to the wild-type SIN1  
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Figure 4-11.  
(A) Stable expression of the SIN1 Ser-260D phospho-mutant showed high 
basal phosphorylation of Akt at Ser-473 and more mTORC2 complex. SIN1-
null MEFs stably expressing WT-SIN1 or the phospho-mutants and grown in 10 
% serum-containing medium. SIN1 immunoprecipitates from stable MEFs were 
used to examine the complex integrity of the mTORC2.  
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or its S260A mutant (Figure 4-11A). This supports our previous results that 
phosphorylation of SIN1 at Ser-260 preserved mTORC2 integrity and this 
complex carried a higher activity.  
Since Akt controls cell proliferation, we hypothesized that SIN1 S260D 
mutation might more robustly promote cell proliferation compared to SIN1-WT or 
S260A mutant. To test this hypothesis, we examined the proliferation rate of the 
SIN1-restored stable MEFs after incubated in 10 % FBS-containing medium for 
48 and 72 hours (Figure 4-11B). First, the proliferation rate of the SIN1-deficient 
MEFs increased by restoration of SIN1-WT (~1.6 times relative to 
unreconstituted SIN1-deficient MEFs). Restoration of the SIN1 S260D mutant 
had more potent effects on cell proliferation compared to that of SIN1-WT (~1.9 
times compared to unreconstituted SIN1-deficient MEFs and 40 % higher than 
SIN1-WT-restored MEFs). The MEFs expressing the SIN1 S260A mutant did not 
proliferate to the same degree as those expressing either WT or S260D mutant 
(~1.3 times relative to unreconstituted SIN1-deficient MEFs and 60 % less than 
MEFs restored with SIN1-WT). These results are coherent with the effects of 
these mutants on mTORC2 signaling (Figure 4-11A). Those MEFs restored with 
SIN1 S260D mutant proliferated at the three times higher rate than those 
reconstituted with S260A mutant. It indicates that regulation of this site is critical 
for the mTORC2-dependent cell proliferation.  
Because mTORC2 kinase activity is sensitive to cellular glucose levels, 
we studied effects of high (5.5 mM) and low (0.55 mM) glucose concentration on 
these SIN1 stable MEFs by analyzing cell proliferation. After incubation at 5.5  
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Figure 4-11.  
(B) Phosphorylation of SIN1 at Ser-260 up-regulates cell proliferation. WT-
SIN1 or the phospho-mutants were reintroduced into SIN1-null MEFs with the 
retroviral expression system. Cell proliferation measurements were performed by 
counting cells 48 and 72 hours after incubation in 10 %-FBS containing medium. 
The ratio of proliferation rate was graphed with GraphPad Prism 5 software.
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mM glucose for 48 hours, we observed a higher basal Akt Ser-473 
phosphorylation in the wild-type SIN1 and S260D mutant-expressing stable 
MEFs compared to those expressing the S260A mutant (Figure 4-11C). The Akt 
signaling activity is consistent with the higher proliferation rate of MEFs 
reconstituted with the wild-type SIN1 or S260D mutant (Figure 4-11D).  
When the stable MEFs were incubated at 0.55 mM glucose for 48 hours, 
we detected a stronger Akt Ser-473 phosphorylation only in MEFs expressing the 
SIN1 S260D mutant that exhibited the higher SIN1 protein abundance (Figure 4-
11C). The SIN1 S260D expressing MEFs displayed a higher proliferation rate 
compared to those reconstituted with the wild-type SIN1 and S260A mutant as 
shown in. Figure 4-11D. These results indicate that phosphorylation of SIN1 at 
Ser-260 maintains mTORC2 integrity and regulates cell proliferation in high or 
low glucose cell culture conditions. 
 
4.12. mTOR-dependent phosphorylation of SIN1 at Ser-260 regulates tumor 
growth 
To address a role of SIN1 phosphorylation in vivo, we studied the effects 
of SIN1 Ser-260 phosphorylation on tumor growth. To develop tumor growth, we 
transformed MEFs restored by WT or mutant SIN1 by overexpressing equal 
amount of H-Ras (Figure 4-12A). Mice injected with the wild-type SIN1 and 
S260D mutant-reconstituted MEFs had bigger tumors than those injected with 
MEFs restored with SIN1 S260A mutant (Figure 4-12A and B). These results 
show that mTOR kinase-dependent SIN1  
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Figure 4-11.  
(C) SIN1-null MEFs stably expressing SIN1 Ser-260D phospho-mutant showed 
high basal phosphorylation of Akt at Ser-473 in 5.5 mM or 0.55 mM glucose 
containing-mediums with the addition of 100 ng/ml IGF-1 for 48 hours. 
Immunoblotting was used to detect the indicated proteins in cell lysates. 
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Figure 4-11.  
(D) SIN1-null MEFs stably expressing SIN1 Ser-260D phospho-mutant 
exhibited higher proliferation rate in physiological and low glucose 
conditions. Cell proliferation measurements were performed by counting cells 
48 hours after incubation in 5.5 mM or 0.55 mM glucose-containing mediums 
with the addition of 100 ng/ml IGF-1 for 48 hours. The ratio of proliferation rate 
was graphed with GraphPad Prism 5 software. 
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Figure 4-12.  Blocking Ser-260 phosphorylation of SIN1 inhibits tumor 
growth.  
(A) MEFs described in Figure 4-11A were transformed by overexpression of the 
oncogenic form of H-Ras and injected into 6-week-old immunodeficient nude 
mice (n = 5 for each group; 3?106 cells per mouse). Tumor size was measured 
after 3, 4 and 5 weeks; the tumor sizes were calculated and the volumes were 
presented by line graph.  
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Figure 4-12.  Blocking Ser-260 phosphorylation of SIN1 inhibits tumor 
growth. 
(B) Mice injected with MEFs expressing each form of SIN1 were sacrificed and 
representative images of the excised tumors are shown.  
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phosphorylation at Ser-260 is pivotal in the regulation of cell proliferation and 
tumor growth. 
 
4.13. Discussion 
Our study demonstrates that the co-transfection of the essential 
components of mTORC2 (mTOR, mLST8, SIN1 and rictor) is able to assemble 
the functional complex with the growth factor-dependent kinase activity. We 
employed the reconstituted mTORC2 to study the role of the mTOR kinase 
domain within mTORC2 to execute Akt phosphorylation at Ser-473. The original 
intention was to eliminate the possibility that unknown kinase co-purified with 
mTORC2 may serve as the Akt Ser-473 kinase. As we expected, the substitution 
of the mTOR-WT with its kinase-dead form prevented mTORC2 kinase activity 
toward Akt. Our data distinctly demonstrates that mTOR kinase within the 
complex of mTORC2 is necessary for Akt phosphorylation at the regulatory Ser-
473 site. This excludes a possibility of any other kinase that may associate with 
mTORC2 and phosphorylate Akt.  
The analysis of the mTORC2 reconstitution system also results in the 
interesting finding implying the essential role of mTOR kinase in controlling 
mTORC2 integrity. Moreover, the mTOR kinase activity is required to preserve 
the protein stability of SIN1 by protecting it from lysosomal degradation. The 
reconstitution of mTORC2 with the mTOR-KD isoform leads to a rapid SIN1 
protein turnover dependent on SIN1 phosphorylation as observed by the 
phosphatase-mediated SIN1 protein migration in the gel. The mTOR-mediated 
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SIN1 phosphorylation does not occur when only SIN1 and rictor are co-
transfected in cells and form a heterodimer. Importantly, the mTOR-dependent 
SIN1 phosphorylation happens only after reconstitution of the functional 
mTORC2. It clarifies a specific role of the mTOR kinase on SIN1 phosphorylation. 
Most likely, SIN1 within mTORC2 complex is constitutively phosphorylated by 
mTOR kinase and this post-translational modification prevents the accelerated 
SIN1 protein degradation. Moreover, the mTOR-mediated SIN1 phosphorylation 
is independent on growth factor signaling since we do not observe mTORC2 
dissociation or SIN1 degradation in cells under serum starvation. Thus, a basal 
mTOR kinase activity in this complex is sufficient to sustain SIN1 phosphorylation.  
In addition to growth factors, mTOR activation is nutrient dependent (such 
as glucose and amino acids) (Guertin and Sabatini, 2007). To identify the 
physiological conditions that affect mTOR-dependent SIN1 phosphorylation, we 
provided nutrients-depletion conditions by incubation of cells in glucose-free or 
amino acids-free cell culture conditions. We found that only glucose starvation 
caused SIN1 degradation and mTORC2 disassembly. Glucose is the essential 
energy source for cells to produce ATP. Therefore, the glucose starvation-
mediated ATP depletion may suppress mTOR function. Indeed, we confirmed 
that mTOR kinase that either exists in mTORC1 or mTORC2 requires at least 1.2 
mM ATP for its full activity indicating its low ATP binding capacity. In contrast, 
other common kinases need only 0.1 mM ATP for their activity (Dennis et al., 
2001). It emphasizes that mTOR kinase activity is highly sensitive to the low 
cellular ATP concentration associated with metabolic stress. These results 
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explained why glucose starvation-dependent ATP deprivation led to mTOR 
inactivation and compromised SIN1 phosphorylation causing a potent negative 
impact on the mTORC2 integrity.  
Our biochemical study of SIN1 phosphorylation identified the potential 
SIN1 phosphorylation site by mTOR as Ser-260. This site carries two important 
features. First, SIN1 possesses a highly conserved region at Box1 of the 
Conserved Region in the Middle (CRIM) domain that is homologous from human 
to drosophila. The Ser-260 site locates within the evolutionally conserved Box1 
and may play a significant role for SIN1 function. Second, the Ser-260 site 
locates within the hydrophobic motif of SIN1. Previous studies showed that 
mTOR kinase phosphorylates the serine residue within the hydrophobic motifs, 
identified in its known substrates: Ser-473 of Akt, Ser-422 of SGK1 and Ser-657 
of PKC? (Alessi et al., 2009). By performing the in vitro assembly of mTORC2, 
we found that SIN1 as the component of mTORC2 is the substrate of mTOR. On 
the other hand, we developed a specific phospho-antibody against Ser-260 
phosphorylation of SIN1 and showed that phosphorylation of SIN1 at Ser-260 
reduced upon mTOR inactivation that was caused by ATP depletion. Thus we 
identified that mTOR phosphorylates SIN1 on the Ser-260 site.   
Our work showed the significance of SIN1 phosphorylation at Ser-260 by 
expressing its phospho-mutants (S260D and S260A) in SIN1 null cells. The SIN1 
S260D mutant that mimics phosphorylation could preserve the complex integrity 
by preventing SIN1 protein degradation. Importantly, a substitution by the wild 
type SIN1 to its S260D phospho-mutant in MEFs displayed a higher mTORC2 
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activity, cell proliferation and tumor growth rates. Our results point out an auto-
regulatory mechanism of mTORC2 by constitutive phosphorylation of SIN1 at 
Ser-260 by mTOR (Figure 4-13). The physiological ATP concentration (1~5 mM) 
is sufficient to maintain basal mTOR kinase activity. Once cells encounter a 
metabolic stress causing a dramatic decrease of ATP level, the ATP-sensitive 
mTOR kinase fails to sustain SIN1 phosphorylation causing SIN1 degradation 
and mTORC2 dissociation. Therefore, the auto-regulatory mechanism 
temporarily shut down the ATP-consuming cell proliferation machinery and 
anabolic processes by disrupting mTORC2 under metabolic stress. 
Phosphorylation of SIN1 at Ser-260 prevents its protein degradation and 
preserves the complex integrity of mTORC2 that further triggers the Akt-
dependent anabolic processes and inducing cell proliferation. Thus, our findings 
provide a novel insight how the homeostatic ATP sensor regulates the mTORC2 
integrity by SIN1 phosphorylation on Ser-260. 
 
? ????
           
Figure 4-13.  ATP-sensitive mTOR kinase-mediated phosphorylation of 
SIN1 at Ser-260 is required to preserve complex integrity of mTORC2 by 
preventing SIN1 degradation 
The mTOR kinase has lower ATP binding affinity and requires sufficient cellular 
ATP concentration. The physiological ATP concentration is 1~5 mM that is 
enough to maintain the full mTOR kinase activity. In addition, the mTOR kinase 
activity is required for SIN1 phosphorylation at Ser-260, which is critical for 
maintaining complex integrity and SIN1 stability. When cells encounter metabolic 
stresses that decline cellular ATP level, deficient mTOR kinase fails to maintain 
the phosphorylation of SIN1 at Ser-260, which results in mTORC2 complex 
dissociation and SIN1 degradation.  
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Our findings identify two distinct regulatory mechanisms of the anabolic 
signaling complex mTORC2 under ER stress and metabolic stress. In Chapter 3, 
our study provides a novel insight in the regulation of mTORC2 under ER stress 
that defines the overlooked balance between two kinases, Akt and GSK-3?. 
Initially, GSK-3? has been identified as a substrate of Akt. In our study, we 
showed that ER stress-inducible GSK-3? becomes the stress inducible upstream 
regulator of the mTORC2-Akt signaling. The phosphorylation of rictor on Ser-
1235 by GSK-3? impairs the substrate binding of mTORC2 and inhibits its kinase 
activity.  
Under ER stress, the GSK-3? kinase is activated as detected by the 
phosphorylation of its substrate glycogen synthase (Ser-641) and auto-
phosphorylation site (Tyr-216). However, how ER stress regulates the activity of 
GSK-3? remains unknown. To identify the regulatory components of GSK-3?, we 
will apply several biochemical approaches: 
(1) Immunoprecipitation: we will immunopurify GSK-3? from cells either under ER 
stress or with treatment of GSK-3? inhibitor, and then subject the samples to 
silver staining analysis. Following identification of the potential regulators by 
Mass Spectrometry analysis, we will study the impacts of the novel GSK-3? 
regulators on the activity of GSK-3? by expression of the recombinant proteins 
and specific shRNAs. 
(2) Size exclusion chromatography: the biochemical purification of the GSK-3? 
regulators is the most challenging and difficult task. We have preliminary data 
based on the enrichment of the GSK-3? through size exclusion chromatography. 
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GSK-3? is located in the fractions of the molecular weight more than 60 kDa 
while the molecular weight of GSK-3? monomer is 46 kDa. This finding indicates 
that regulator might associate with GSK-3? in a complex. In this co-purification 
study the different types of detergents and chemical cross-linkers will be applied 
to stabilize the GSK-3? complex.  
As an alternative approach to enrich the regulators we will perform the 
differential centrifugation prior to size exclusion chromatography. Differential 
centrifugation is a useful technique to separate the organelles from a 
homogenous solution of particles based on their densities. In this case, we can 
pre-isolate the cell fractions containing the GSK-3? effectors before the next-step 
purification. Moreover, we will conduct the ionic exchange chromatography to 
further purify and enrich the effectors. When we obtain the relatively pure 
fraction, we will perform mass spectrometric analysis to identify the specific GSK-
3? regulators. 
 The biological relevance of mTORC2 regulation by ER stress is an 
important part of our future studies. ER stress is highly associated with metabolic 
diseases including type II diabetes. The initial stage of the type II diabetes is 
characterized by insulin resistance-- the peripheral tissues (muscle, fat and liver) 
fail to respond to insulin, leading to deficient glucose uptake. Previous mouse 
genetic models also linked GSK-3? with insulin resistance. GSK-3? is linked to 
insulin signaling by phosphorylating glycogen synthase known to lead to 
inhibition of glycogen synthesis and decrease of the cellular sensitivity to insulin. 
In our study, the negative regulation of Akt by GSK-3? may represent another 
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mechanism that contributes to insulin resistance.  
 To study the effects of rictor Ser-1235 phosphorylation on Akt-dependent 
glucose metabolism, we are in a process of generating rictor “phospho-mutants- 
knock-in” mice and analyze their phenotypes. It becomes clear that obesity 
causes ER stress and contributes to the development of type II diabetes. We will 
feed the rictor “phospho-mutants-knock-in” mice with high-fat diet (HFD) to 
induce obesity and ER stress. Then, we will conduct glucose tolerance tests 
(GTT) and insulin tolerance tests (ITT) in these mice to examine their systemic 
insulin sensitivity and glucose homeostasis. 
To follow up the studies of the mouse phenotype, we plan to apply MEFs 
from the rictor “phospho-mutants-knock-in” mouse embryos, and study the 
impact of GSK-3?-mediated rictor phosphorylation on glucose uptake. To dissect 
the effects of GSK-3? on glucose uptake, we will first treat the MEFs with ER 
stress inducers (thapsigargin or tunicamycin) to activate GSK-3?. Subsequently, 
we will apply 2-NBDG (a new fluorescent derivative of glucose) and measure the 
rates of glucose uptake. Alternatively, we will test other insulin-sensitive tissues, 
such as skeletal muscle, adipose or liver tissues, to observe more significant 
glucose uptake.  
 
Our studies also define the ATP-dependent auto-regulation of mTORC2. 
In Chapter 4, our results indicate that mTOR is a highly sensitive kinase to the 
cellular ATP level under metabolic stress induced by glucose deprivation or acute 
ATP depletion. We found that mTOR is the Ser-260 kinase of SIN1. Without 
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phosphorylation at Ser-260 by functional mTOR kinase, SIN1 remains unstable 
and undergoes lysosomal degradation. Our data indicate that SIN1 Ser-260 
phosphorylation is required to maintain SIN1 stability and complex integrity. Does 
this phosphorylation event directly control mTORC2 assembly or indirectly 
preserve complex integrity by simply protecting SIN1 from lysosomal 
degradation?  
To test the first possibility, we will apply SIN1-WT and its phospho-
mutants to the in vitro mTORC2 reconstitution system (Chen and Sarbassov dos, 
2011). If the SIN1 mutants do not affect the complex assembly, then we will 
examine the second possibility. To check if SIN1 phosphorylation indirectly 
maintains mTORC2 integrity, we will treat the SIN1-WT, S260D, and S260A-
restored MEFs with the lysosomal inhibitor (chloroquine), and analyze the 
complex by SIN1 immunoprecipitation. If the inhibition of SIN1 degradation can 
enrich the complex level of mTORC2 containing SIN1-S260A mutant, then the 
second possibility is correct.  
Moreover, how SIN1 phosphorylation prevents its lysosomal degradation 
is an intriguing question. Autophagy is a cellular catabolic process that integrates 
with lysosome for protein degradation. To study if autophagy is involved, we can 
knock down the critical components of the autophagic pathway (ATG5 and 
ATG7) using the shRNA lentiviral system. To further analyze SIN1 transportation 
to lysosomes for degradation, we will purify the lysosomal fractions from 
metabolic stressed cells treated with or without chloroquine, and determine SIN1 
protein amount. This biochemical study will validate if SIN1 protein is directly 
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targeted to lysosome for degradation.  
The SIN1 Ser-260 phospho-mutants will be highly valuable because the 
SIN1 S260D mutant is much more stable form and targeting of SIN1 for 
degradation is prevented by its Ser-260 phosphorylation. We propose that 
assembly of the SIN1 lysosomal targeting complex will be actively formed with 
the wild type or its S260A mutant but not with its phospho-mimetic S260D 
mutant. Based on this assumption, we will focus on identification of the proteins 
co-purified with the wild type SIN1 or S260A mutant. We will extend this study by 
characterizing the SIN1 complex in the lysosomal fractions that might lead to 
understanding of the selective lysosomal degradation pathway. The identified 
components of the SIN1 degradation complex will be validated by expression of 
the recombinant proteins and also specific shRNAs.  
In our study, the ATP-sensing mechanism of mTORC2 explains how this 
anabolic signaling complex disintegrates under metabolic stress. Another stress 
responsive kinase, AMPK (AMP-activated protein kinase), is activated by low 
cellular ATP level. It is possible that AMPK may involve in the regulation of the 
mTORC2 under metabolic stress. To test this possibility, we will apply the AMPK 
inhibitor (Compound C) in cells under glucose starvation or acute ATP depletion 
conditions and study the mTORC2 activity, integrity, and SIN1 stability. 
Alternatively, we may employ the AMPK-null MEFs to see if AMPK contributes to 
mTORC2 regulation. 
 
Overall, we identify two different regulatory mechanisms of mTORC2 by 
? ????
the essential components rictor and SIN1. These two projects provide novel 
insights into the regulation of mTORC2 under cellular stress conditions. We will 
need the future studies to extend our knowledge in the field of the mTORC2-Akt 
signaling pathway.  
 
? ????
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